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ABSTRACT 
The majority of solid tumors are characterized by aneuploidy that is believed to be the 
consequence of chromosomal instability (CIN). The mechanisms leading to aneuploidy 
and the pathway (s) that allows its tolerance are not completely understood. The Spindle 
Assembly Checkpoint (SAC) is a cellular surveillance mechanism that works to maintain 
the genomic balance in mitosis. Alterations of SAC components can induce aneuploidy but 
it is not clear if these defects are sufficient for tumorigenesis. In this process the genetic 
background of the cell plays an important role. It is known that p53 defects allow cells to 
quickly proliferate tolerating CIN. On the contrary, activation of wt-p53 counteracts 
aneuploidy. Less is known about the role of the p14
ARF
 tumor suppressor to counteract 
aneuploidy.  
In this thesis I investigate the relationship between some of the SAC genes that if depleted 
induce aneuploidy and tumor suppressor genes. First, to investigate the role of p14
ARF
 to 
counteract aneuploidy it was ectopically expressed in HCT116 cells (near diploid) after 
MAD2 depletion a crucial component of the SAC. MAD2 posttranscriptional silencing 
induced high levels of aneuploid cells and aberrant mitosis that decreased when p14
ARF
 
was simultaneously expressed. In addition, p14
ARF
 ectopic expression in MAD2-depleted 
cells induced apoptosis associated with increased p53 protein levels. This response was not 
detected in HCT116 p53KO cells suggesting that p14
ARF
 counteracts aneuploidy activating 
apoptosis p53-dependent. Second, I wanted to probe the relationship between the motor 
protein CENP-E, which works only in the SAC signaling, and aneuploidy in human cells. 
To this aim I used two types of cells, human primary fibroblasts (IMR90) and near diploid 
cells (HCT116) lacking p14
ARF
, and analyzed the effects of CENP-E depletion up to four 
weeks. These experiments showed a different response for the two cell types. Aneuploidy 
was tolerated for longer times in cells lacking p14
ARF
 expression rather than in primary 
cells. In addition the observations that the reduction of aneuploidy in IMR90 cells was 
proportional to the increase of p14
ARF
 gene expression, and that its ectopic expression in 
HCT116 cells reduced aneuploidy confirm the ability of p14
ARF
 to counteract aneuploidy. 
Third, to improve these results I generated HCT116 cells expressing a functional p14
ARF
 to 
assess the effects of CENP-E depletion. Collectively, these results suggest that the tumor 
suppressor p14
ARF
 may have an important role to contrast aneuploidy activating a p53-
dependent apoptosis pathway and that it is generally involved to counterbalance 
aneuploidy induced by different stimuli.  
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CHAPTER 1: INTRODUCTION 
For all living organisms transferring hereditary information from mother cell to 
daughter cell is a crucial step and highly controlled. Eukaryotes store their hereditary 
information on separate chromosomes within their nuclei. Diploid organisms contain two 
of each chromosome type (2N). A normal human cells exhibits 23 pairs of chromosomes, 
22 pairs of autosomes and one pair of heterosomes (XX and XY) that determine the sex. 
During cell division, cells duplicate their DNA which is equally distributed onto the 
daughter cells, thus generating two cells with exactly the same genetic information. 
Genome integrity is maintained by different checkpoints activated in the various phases of 
the cell cycle. Mitosis, one of the two main phases that are part of the cell cycle, forms the 
basis for cellular proliferation and normal development of any organism. During this 
process many mitotic events are involved to control a perfect coordination between several 
signaling cascades and more than a hundred different proteins that work together to ensure 
fidelity of cell division. The most important mitotic checkpoint is the Spindle Assembly 
Checkpoint (SAC) that prevents wrong chromosome segregations which could lead to 
form daughter cells with an abnormal chromosome numbers and/or structurally deformed 
chromosomes, an event known as aneuploidy.  
1.1 SPINDLE ASSEMBLY CHECKPOINT 
Mitosis is the most vulnerable stage of the cell cycle because DNA damage cannot 
be repaired when the chromosomes are condensed and because the kinetochore attacks to 
microtubules is a stochastic nature event (Rieder & Maiato 2004). Consequently, all sister 
chromatids are not captured simultaneously by the spindle fibers so eukaryotic cells have 
developed a control point called Spindle Assembly Checkpoint (SAC), which is active 
both in the absence of a proper strength of kinetochore-microtubule tension and when the 
kinetochore is not properly attached to the spindle fibers. The SAC aims to maintain 
genomic balance by facilitating equal segregation of chromosomes between the two 
daughter cells (Musacchio 2015). SAC dysfunctions can cause numerical chromosome 
changes that is an event linked with stimulation of malignant cell growth (Kops et al. 
2005). 
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1.1.1 SAC Activation 
SAC is activated in early mitosis to monitor the attachments between microtubules 
and chromosomes kinetochores working to prevent aneuploidy caused by improper sister  
chromatid separations (Musacchio 2015). The improper or absent attachment of even a 
single chromosome with the spindle microtubules generates a STOP signal called "wait 
anaphase" which activates the SAC and prevents the metaphase-anaphase transition to help 
the cell to provide the time needed for all kinetochores are captured by the spindle fibers 
with the development of proper tension (Silva et al. 2011). However, the SAC activation in 
a cell depends on the presence of at least one of the following: the number of unattached 
kinetochores (Dick & Gerlich 2013), the amount of mitotic arrest deficient 2 (Mad2) 
protein at the unattached kinetochores, the amount of Mitotic Checkpoint Complex (MCC) 
formed (Collin et al. 2013). 
The proteins involved in the SAC pathway are divided into two groups: the first 
includes the proteins that form the so-called "bona fide SAC components" (i.e. Mad1, 
Mad2, Bub1, BubR1, Bub3, Mps1) while the second includes the proteins involved in the 
regulation of APC/C and in the interaction with proteins of the SAC (Khodjakov & Rieder 
2001). Most of these proteins are believed to act as catalyst for the accumulation of the 
SAC effector and a reversible protein phosphorylation is a crucial regulator of the SAC 
signaling. The SAC effector is named the Mitotic Checkpoint Complex (MCC) that targets 
the anaphase-promoting complex or cyclosome (APC/C) (Fig.1). This complex can bind 
stably to APC/C thereby inhibiting its E3 ubiquitin ligase activity necessary to target 
several mitotic proteins for degradation. MCC complex is involved in the inhibition of 
Cdc20 protein, a co-activator of APC/C complex. By inhibiting Cdc20, the SAC efficiently 
inhibits the APC/C and halts mitotic progression by preventing the degradation of two 
mitotic key substrates: securin and cyclin B1. Securin is an inhibitor of separase, a protease 
that cleaves a cohesin subunit allowing sister chromatid separation, and cyclin B1 is an 
activator of CDK1, the major mitotic kinase. The kinetochore plays a crucial role in the 
activation of SAC pathway because all SAC components are recruited to unattached 
kinetochores where they exhibit a rapid turnover and where the signal is generated.  In fact, 
Cdc20 is recruited to kinetochores and incorporated into the inhibitory complex MCC. 
Once all kinetochores are correctly attached to microtubules the MCC complex 
disassembles and the APC/C-Cdc20 complex become active and triggers anaphase entry 
(Foley & Kapoor 2013; London & Biggins 2014b). 
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Fig.1. The SAC mechanism (Musacchio 2015). 
 
1.1.1.1 KMN Network and regulation of kinetochore-microtubule interaction  
The microtubule binding activity of the kinetochore constituted by the KNL1-
Mis12-Ndc80 complex (KMN network) is the major binding site for SAC proteins at the 
outer kinetochore (Varma et al. 2013). Ndc80 complex and KNL1 are docking site for 
checkpoint proteins. The KMN network is the fulcrum of the sensory mechanism of the 
SAC (London & Biggins 2014b). Aurora B appears to be crucial for this operation as it is 
required for kinetochore recruitment of Mps1 kinase and it also counteract the recruitment 
of the SAC-silencing phosphatase PP1 (Lampson & Cheeseman 2011). Aurora B, a 
serine/threonine (S/T) protein kinase, is a subunit of a complex named the chromosome 
passenger complex (CPC). During mitosis it is greatly enriched in the region between 
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kinetochores from which it can phosphorylate kinetochore substrates, including 
centromeric protein A (CENP-A) in the inner kinetochore and the subunits of the KMN 
network in the outer kinetochore (Carmena et al. 2012). Aurora B-dependent 
phosphorylation of kinetochore substrates is strictly linked to the state of kinetochore-
microtubule attachment, and declines when bi-orientation ensues (Emanuele et al. 2008). 
The basic tails of Ndc80 contains numerous phosphorylation sites for the Aurora B kinase 
and these are phosphorylated in response to improper kinetochore-microtubule 
interactions, thereby destabilizing the interaction. As Aurora B is concentrated at the 
centromere region this establishes a gradient of Aurora B activity and proper kinetochore-
microtubule attachments move the KMN network away from Aurora B activity thus 
stabilizing the binding (Welburn et al. 2010). Furthermore, Aurora B makes a crucial 
contribution to SAC signal because it is essential for recruitment of Mps1 to kinetochore 
whose activity is required for kinetochore recruitment of all downstream component of 
MCC complex. Instead Mps1 and Aurora B kinase constitute the most upstream 
components of the checkpoint (Heinrich et al. 2012; Saurin et al. 2011). Mps1 
phosphorylates the phosphodomain of KNL1 (MELT motifs), thus creating docking sites 
for the recruitment of additional SAC proteins, including Bub3, Bub1, BubR1 (known as 
MAD3 in yeast), MAD1, MAD2, and Cdc20, which play a crucial role in the assembly of 
MCC, either as MCC subunits or by supporting MCC assembly (Fig.2) (Musacchio 2015). 
 
 
Fig.2. Recruitment of MCC complex (Musacchio 2015). 
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1.1.1.2  Mitotic Checkpoint Complex (MCC) 
The MCC complex serves as an effector for the SAC because it physically interacts 
with APC/C to negatively affect its ubiquitin ligase activity in response to the presence of 
unattached kinetochores in a mitotic cell (Hein & Nilsson 2014). The individual 
components of MCC are known to dynamically exchange between the cytosol and 
unattached kinetochores (Howell et al. 2004; Shah et al. 2004). However, the precise 
molecular mechanisms controlling this protein trafficking are not known, and the exact 
composition of MCC in time and cellular space is also poorly understood. The MCC is 
formed by the association of MAD2, BubR1 and Bub3 with Cdc20.  BubR1 is the largest 
protein in the MCC and is able to interact with two Cdc20 molecules via its KEN1 and 
KEN2 motifs (Izawa & Pines 2015; Ibrahim 2015). It can also bind Bub3 via its GLEBS 
motif (Overlack et al. 2015), dimerize with budding uninhibited by benzimidazole-1 
(Bub1) using extended loop helix (Lischetti et al. 2014) and interact with PP2A 
phosphatase through a kinetochore attachment regulatory (KARD) domain (Suijkerbuijk et 
al. 2012). MAD2 is a SAC protein that exists in two structural conformations, namely 
open-MAD2 (O-MAD2) and closed-MAD2 (C-MAD2), to control APC/C activity (Luo & 
Yu 2008; Mapelli & Musacchio 2007). Bub3 contains a WD40 β-propeller domain and it 
forms a complex with Bub1 and BubR1 to recruit them to the kinetochores (Taylor et al. 
1998). Cdc20 has a wide range of binding partners like APC/C subunits, MAD2, BubR1, 
Bub1 and several mitotic substrates of APC/C (Musacchio 2015). The binding of MCC to 
Cdc20 prevents Cdc20 binding to mitotic substrates proteins (Chao et al. 2012). 
The assembly of MCC at unattached kinetochores is a step-wise process (Fig.3). 
Once Mps1 is located and active at kinetochore, it stimulates recruitment of the Bub1-
Bub3 complex, which is needed for recruitment of BubR1-Bub3 and MAD1-MAD2 
(London & Biggins 2014b). Initially it is important Mps1 phosphorylation of outer 
kinetochore KNL1 protein which works as a receptor of Bub1 and BubR1 through two 
distinct KI motifs located in the N-terminal region. These KI motifs make contact 
specifically with the TRP domains of Bub1 and BubR1 (Kiyomitsu et al. 2011). However 
for Bub1 and BubR1 localization is dispensable an additional mechanism contributes. For 
Bub1 kinetochore localization is required that Mps1 phosphorylates MELT motifs in 
KNL1 and binding to them depends on Bub3 which acts as a signaling adaptor to form a 
complex with BubR1 and Bub1 (Musacchio 2015).  Thus, the Bub3:Bub1 complex recruits 
BubR1:Bub3.  
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While Bub1/3 localization is required for the checkpoint, its localization does not 
always correlate with checkpoint activation. In contrast, MAD1/2 kinetochore localization 
is strictly correlated with checkpoint signaling and activation (Kuijt et al. 2014). The 
middle part of Bub1 is the direct kinetochore receptor for MAD1-MAD2 and this 
interaction depends on Mps1 phosphorylation of this region of Bub1 (London & Biggins 
2014a). However, in human cells, MAD1 may require the additional receptor 
Rod/Zwilch/Zw10 complex (RZZ). KNL1 and its constitutive binding partner Zwint are 
required to localize RZZ which localization may be regulated through Aurora B 
phosphorylation of Zwint (Varma et al. 2013; Kasuboski et al. 2011). Furthermore, RZZ 
complex localizes dynein, a minus-end directed microtubule motor, to kinetochores 
through the adaptor protein Spindly. This allows dynein to remove MAD1-MAD2 from 
kinetochores once they have attached to microtubules. Probably, a combined binding 
interface composed of Bub1 and the RZZ complex mediates the interaction with MAD1 in 
human cells (Barisic & Geley 2011).  
 
Fig.3. Kinetochore activation of the checkpoint through checkpoint protein recruitment (London & 
Biggins 2014b). 
 
The loading onto kinetochores of the tetrameric MAD1–MAD2 complex, 
composed of a stable MAD1 dimer with each member bound to a MAD2 molecule, is the 
event that finally engages the SAC but the limiting step is the binding of MAD2 to Cdc20. 
MAD2 exists in at least 2 extreme conformations, open (O-MAD2) and closed (C-MAD2), 
the latter being able to bind MAD1 and Cdc20. The “template model” (details in a separate 
1.1.2 MAD2 paragraph) suggests that MAD1-MAD2 complex recruits O-MAD2 to 
kinetochores and this stimulates the conversion of soluble O-MAD2 into soluble C-MAD2 
that can then bind Cdc20,  essential for efficient SAC signaling (De Antoni et al. 2005). It 
was originally proposed that MCC (MCC “core”) contains a single copy of MAD2, 
BubR1, Bub3, and Cdc20 (Sudakin et al. 2001). However, it was showed that a MCC 
“core” may also bind a second molecule of Cdc20 to form MCC2Cdc20 (Izawa & Pines 
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2015). This is possible thanks to two KEN domains of BubR1 that allow it to interact with 
Cdc20 and MAD2 protein is required for this bond, so Mad2 and BubR1 synergize to 
inhibit Cdc20-mediated activation of APC/C (Fig.4)  (Burton & Solomon 2007; Fang 
2002).  
 
Fig.4. MCC complex (Musacchio 2015) 
 
1.1.1.3  SAC Silencing 
Recent studies have shown that rather than the intra-kinetochore tension, the stable 
microtubule attachments at the kinetochores is a major driver for SAC inactivation 
(Tauchman et al. 2015; Etemad et al. 2015). The rapid activation of APC/C–Cdc20 in 
response to attachment of the last kinetochore suggests that Cdc20 is quickly liberated 
from inhibition. The generation of active Cdc20 consists of at least 2 steps, namely killing 
of the kinetochore signal and disassembly of existing MCC complexes. 
Silencing the kinetochore signal requires the removal of the checkpoint proteins 
from the kinetochore. At least two independent mechanisms lead to MAD1-MAD2 
kinetochore dissociation dynein-mediated: a) stripping of checkpoint proteins and b) 
reversal of activating phosphorylation through phosphatase activity. The first mechanism 
consists of the motor protein dynein that localizes to the kinetochore through RZZ/Spindly. 
MAD1-MAD2 and BubR1 are also removed by dynein during this process, coupling 
microtubule binding to stripping of kinetochore checkpoint proteins (Gassmann et al. 2010; 
Barisic & Geley 2011). The MAD1-MAD2 complex is also inhibited by “capping” of C-
MAD2 by p31
comet
, which prevents binding of O-MAD2 to the complex once it is removed 
from kinetochores (Fava et al. 2011). The second mechanism involves protein 
phosphatase1 (PP1) recruitment for SAC silencing and his activity requires its interaction 
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with kinetochores. KNL1 contains a conserved PP1 binding site close to the region of 
KNL1 that interacts with microtubules, and the link of PP1 to KNL1 contributes to SAC 
silencing. A model for PP1-mediated SAC silencing is thus dephosphorization of MELT 
motifs to remove Bub1 and BubR1 from kinetochores (Rosenberg et al. 2011; Espeut et al. 
2012).  The PP1 binding site on KNL1 contains a phosphorylation site for Aurora B, which 
when phosphorylated prevents PP1 binding. Thus, PP1 and Aurora B antagonize each 
other on the outer kinetochore and when microtubules bind the balance tips toward PP1 
binding and SAC silencing  (Liu et al. 2010).  
MCC and APC/C–MCC are stable complexes and their disassembly is an active 
process but the exact mechanism is not clear. At least 2 distinct pathways have been 
suggested to remove MAD2 from Cdc20: a p31
comet
-catalyzed mechanism and APC/C-
mediated ubiquitination of Cdc20. p31
comet
 binds to C-MAD2 present in MCC functioning  
as an endogenous MAD2 inhibitor and also promotes the Cdk-dependent phosphorylation 
of Cdc20 to release Cdc20 from MCC (Chao et al. 2012; Varetti et al. 2011). To facilitate 
efficient C-MAD2 removal p31
comet
 might collaborate with the AAA-ATPase TRIP13 
(Eitan et al. 2014). A second proposed mechanism of MCC dissociation, which would be 
specific for APC/C bound MCC, is ubiquitination of Cdc20 by the APC/C, a process 
regulated by APC15 (Mansfeld et al. 2011). 
1.1.2  Mitotic Arrest Deficient (MAD2)  
The heart of the SAC is MAD2 (Mitotic Arrest Deficient 2), a conserved ∼200-
residue protein, highly conserved in eukaryotes. Its main task is to safeguard the event of 
chromosomes segregation from possible errors during mitosis. The MAD2 protein has a 
central role in generation of the MCC and co-ordination of the early mitotic events with the 
SAC activity. It is a component of Mitotic Arrest Deficient proteins, that include also 
MAD1 and MAD3 (BubR1 in humans), initially identified in yeast as important regulators 
of the mitotic checkpoint and then confirmed in humans (Li & Benezra 1996).  
As said MAD2 exists in at least 2 extreme conformations, open O-MAD2 and 
closed C-MAD2, differing in the position of secondary structure elements in the N- and C-
terminal regions (Fig.5). The C-MAD2 conformation is able to bind MAD1 and Cdc20 to 
form the MCC complex. The structural properties of O-MAD2 do not permit the formation 
of O-MAD2:O-MAD2 homodimer and O-MAD2:Cdc20 heterodimer. Conversely, C-
MAD2 is able to form a homodimer with C-MAD2 and heterodimers with O-MAD2, 
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Cdc20 and MAD1. Importantly, C-MAD2 protein presents the same binding region for 
both MAD1 and Cdc20, which leads to competition between the two proteins for C-MAD2 
binding (Mapelli et al. 2007). Prior to activation of the checkpoint, MAD2 is located in the 
cytoplasm in monomeric free from and undergoes a conformational change in the  active 
form C-MAD2 when is recruited to the kinetochores not attached to the spindle fibers, 
thanks to the interaction with the heterodimer MAD1-MAD2 (Skinner et al. 2008). In fact, 
during mitosis, the recruitment of MAD2 to the unattached kinetochores is dependent on 
MAD1 and the presence of MAD1 bound C-MAD2 at the kinetochores determines the rate 
of MCC formation (De Antoni et al. 2005). 
 
 
Fig.5. Multiple conformations of MAD2 (Yu 2006). 
 
How  the MAD1-MAD2 complex interacts with the kinetochore is still unclear but 
it was proposed that Bub1 works as the direct receptor and this interaction depends on 
Mps1 phosphorylation of Bub1 (London & Biggins 2014a). 
 To explain how the conformational change of MAD2 happens, initially was 
proposed the "Exchange Model model", in which the interaction of the COOH-terminal of 
MAD2 with MAD1 promoted the shift toward the closed configuration. As Cdc20 interacts 
with MAD2 in the same site linked from MAD1, it was thought that there be a competition 
between the two proteins MAD1 and Cdc20 that allow the posting of C-MAD2 from the 
MAD1 protein (Luo et al. 2002).  The problem of this model was that the affinity of 
MAD1-MAD2 and Cdc20-MAD2 complex are too high to allow a rapid exchange of 
MAD2 between the two proteins. On the contrary, the “Template Model” for MAD2 
activation suggests that the kinetochore localized MAD1–MAD2 complex recruits O-
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MAD2 to kinetochores through dimerization with C-MAD2 bound to MAD1 and this 
stimulates the conversion of soluble O-MAD2 into soluble C-MAD2 that can then bind 
Cdc20 (De Antoni et al. 2005). This model identified MAD1-bound C-MAD2 as a 
template for O-MAD2 conversion into a Cdc20-bound C-MAD2 copy. The conformational 
dimerization of MAD2 appears to be a transient interaction between an O-MAD2 subunit 
and a spatially localized rigid scaffold, the MAD1:C-MAD2 complex (Mapelli & 
Musacchio 2007).  
These interactions might be directly regulated by Mps1 at kinetochores as Mps1 
stimulates O-MAD2 recruitment in human cells (Hewitt et al. 2010). Indeed, O-MAD2 
activation has been reconstituted with purified proteins but the low rates measured in vitro 
might suggest that kinetochores provide additional layers of catalysis and one of these is 
probably MAD1 (Simonetta et al. 2009; Kruse et al. 2014). The silencing of the pathway is 
due to the intervention of p31
comet
 protein which promotes the exit from mitosis by binding 
to C-MAD2, and obtaining the release of Cdc20 ready to active the APC /C complex (De 
Antoni et al. 2005). 
In addition, it should be noted that also in interphase cells, the MAD1:C-MAD2 
complex forms at the nuclear envelope to produce Cdc20 inhibitor complex during 
interphase to avoid the premature degradation of Cyclin B and securin that upon entry to M 
phase leads to precocious anaphase (Rodriguez-Bravo et al. 2014).  
Under normal growth conditions, functional inactivation of MAD2 induces cellular 
senescence and causes defects in the response of the cells to DNA damage (Lentini et al. 
2012; Lawrence et al. 2015). In addition, the deregulation of MAD2 generates significant 
mitotic anomalies as the deletion of even one of MAD2 allele increases the chromosomal 
instability of the cell (Musacchio & Salmon 2007). It was found that MAD2 deregulation 
in the cells induces premature sister chromatids separation and aneuploidy (Meraldi et al. 
2004; Lentini et al. 2012; Veneziano et al. 2016).  
1.1.3  Centromere Associated Protein E (CENP-E)  
Accurate chromosome segregation during mitosis requires the bipolar attachment of 
kinetochore of duplicated chromosomes to spindle microtubules emanating from opposite 
poles (Cleveland et al. 2003). Microtubule capture by the kinetochore is a stochastic 
process. Although some chromosomes achieve biorientation without being transported to 
the spindle pole, dynein-mediated transport is an important mechanism to collect 
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chromosomes to a common microtubule-dense region, where kinetochores have a greater 
chance of promoting efficient chromosome alignment. 
In this process an important role is mediated by CENP-E (Centromere Associated 
Protein-E), a plus-end directed kinesin-7 motor protein of 312kDa (in human cells) 
required for chromosome segregation in both mitosis and meiosis ( Yen et al. 1992; Schaar 
et al. 1997; Kim et al. 2008) . CENP-E protein accumulates in late G2, functions during 
mitosis, and is degraded at the end of mitosis as quantitatively as cyclin B (Brown et al. 
1994). During mitosis, CENP-E localizes to kinetochores, where it is one of a number of 
proteins that serve as linkers between chromosomes and the microtubules of the mitotic 
spindle (Gudimchuk et al. 2013). It has a long coiled-coil region separating the motor 
domain near its N-terminus from a C-terminal domain that contains sites responsible for 
association with the kinetochore. The process of capturing spindle microtubules by 
kinetochores is prone to errors. Undesirable attachment frequently occurs in early 
prometaphase, with a single kinetochore capturing microtubules from both spindle poles 
(merotelic attachment), or both sister kinetochores attached to the same pole (syntelic 
attachment) (Cimini & Degrassi 2005). It was found that CENP-E possesses a highly 
flexible and very long coiled-coil that raises the possibility that it may also contribute, in 
part, to the inappropriate attachments of kinetochores (Kim et al. 2008). These improper 
kinetochore attachments, if not resolved, can lead to chromosome missegregation and 
aneuploidy (Holland & Cleveland 2009). 
CENP-E also functions in the spindle assembly checkpoint (SAC) to prevent 
chromosome missegregation and aneuploidy (Abrieu et al. 2000; Weaver et al. 2003). 
CENP-E association with the kinetochore has been reported to be mediated by a large 
number of kinetochore-associated proteins with which it interacts, including the 
centromeric protein F (CENP-F), NUF2, and SKAP (Huang et al. 2012; Liu et al. 2007). 
Also CENP-E binds and, in the absence of bound microtubules, activates the SAC kinase 
BubR1 forming a stable ternary complex (spindle microtubule/CENP-E/BubR1) and 
producing checkpoint signaling that is silenced either by spindle microtubule capture or the 
tension developed at kinetochores (Mao et al. 2005).  
It was identified that CENP-E can be multiply phosphorylated during mitosis 
(Nousiainen et al. 2006). However, the significance of all of these phosphorylations has not 
been established but some of these can regulate CENP-E functions. Phosphorylation of the 
C-terminal tail of CENP-E by Cdk1, MAPK, or Mps1 has been proposed either to regulate 
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CENP-E motor activity prior to its binding to kinetochores or inhibit a microtubule binding 
site in the tail (Espeut et al. 2008). Furthermore,  it was discovered an Aurora/PP1 
phosphorylation switch that is required not only for congression of polar chromosomes 
through modulation of the intrinsic motor properties of CENP-E, but also for subsequent 
stable biorientation of those chromosomes (Kim et al. 2010). In the regulation of CENP-E, 
the Aurora kinase activity is opposed by Protein Phosphatase 1 (PP1) functions (Liu et al. 
2010). It has been shown that PP1 can localize at outer of kinetochore and it can stabilize 
kinetochore-microtubule attachment by counteracting Aurora B kinase activity. In 
particular, Aurora kinases, both A and B, phosphorylate a single conserved residue close to 
the CENP-E motor domain while PP1 has a docking domain that overlaps the site of 
phosphorylation so the PP1 bind to CENP-E is disrupted by Aurora mediated 
phosphorylation. Aurora A phosphorylates CENP-E near the spindle poles, releasing PP1 
from CENP-E. CENP-E phosphorylated is active and able to bind the microtubules to 
KMN network on the kinetochore thus to carry the chromosomes the spindle equator along 
the K-fiber of an already bioriented chromosome (Kapoor et al. 2006). As chromosomes 
congress, kinetochores move away from the Aurora A gradient concentrated at the spindle 
poles and CENP-E is dephosphorylated and recruits a high local concentration of PP1 to 
the outer kinetochores of chromosomes so it has translocated away from a pole. CENP-E 
delivered PP1 and dephosphorylation of kinetochore key components, such as Ndc80 and 
KNL1, is essential for stable kinetochore-microtubule interactions (Fig.6) (Kim et al. 
2010).   
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Fig.6. CENP-E regulation by Aurora kinases and PP1 (Kim et al. 2010). 
 
 
.  
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1.2 ANEUPLOIDY AND CANCER 
Cancer is the result of cells that have undergone unregulated growth as a 
consequence of defects in one or more regulatory signaling pathways. The development of 
cancer is usually a multistep process and one of its fundamental features is tumor clonality, 
the development of tumors from single cells that begin to proliferate abnormally. One of 
the hallmarks of cancer, especially solid tumor, is aneuploidy but its role in the process of 
carcinogenesis is not yet well defined.  
A functional mitotic checkpoint can avoid aberrant chromosome content which can 
generate aneuploidy or polyploidy. Polyploidy describes a chromosome content which is a 
multiple of the parental euploid karyotype and it is a common phenomenon in nature 
(Hollister 2015). In contrast, aneuploidy is a change in chromosomes number or structure 
that are not a multiple of the whole chromosome set and it is usually not well-tolerated by 
cells. Exception trisomy 21 (Down syndrome), trisomy 13 and 18, no other aneuploid 
disorders were found to be compatible with live and most aneuploidies affecting the whole 
organism are lethal. Aneuploidy can arise either by gain or loss of few intact chromosomes 
(chromosomal aneuploidy) or by chromosome rearrangements such as translocations, 
inversions, amplifications and deletions (segmental or structural aneuploidy) (Janssen et al. 
2011).  
More than a century ago, Theodar Boveri (Boveri, 1914) led to a hypothesis that 
aberrant mitosis would generate cells with different chromosome content that might 
contribute to tumorigenesis. In recent years, different results have clarified the molecular 
mechanisms involved in this process although many of these are conflicting results about 
the role of aneuploidy in carcinogenesis (Weaver et al. 2007; Torres et al. 2008). 
Remembering the famous incipit of the book “Anna Karenina” we could be say that the 
aneuploid tumors are like unhappy families of Tolstoj: each tumor has its particular 
content of abnormal chromosomes and consequently their atypical features (Pellman 
2007).  
It is important to separate aneuploidy from chromosomal instability (CIN) which is 
as well as aneuploidy a frequent hallmark of cancer. Whereas aneuploidy describes the 
present state of the genomic material, chromosomal instability describes ongoing 
missegregation of different chromosomes (Holland & Cleveland 2009). Every cell with 
CIN can be aneuploid whereas not every aneuploid cell is genomically unstable, as shown 
in cells from Down syndrome patients (Gordon et al. 2012). 
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1.2.1 Origins of Aneuploidy  
Chromosome missegregation can either happen randomly or due to mutations 
leading to defects in spindle assembly checkpoint (SAC), sister chromatid cohesion, 
aberrant mitosis or merotelic attachment (Fig.7). In contrast, structural aneuploidies can 
result from errors in DNA replication and repair. 
 
 
Fig.7. Origins of chromosome aneuploidy (Siegel & Amon 2012) 
  
1.2.1.1 Spindle Assembly Checkpoint Defects 
Several studies have reported induction of aneuploidy and tumor formation in cell 
culture and mouse models as a consequence of deregulation of SAC proteins. A complete 
knockout of many spindle checkpoint genes, such as genes encoding for Bub3 and MAD2, 
were shown to be embryonic lethal (Dobles et al. 2000; Kalitsis et al. 2000). However, 
mice with impaired SAC survive and their cells can divide even though the chromosomes 
are not aligned properly leading to chromosomally instable cells (Fig. 7A). This was shown 
by Michel and colleagues that generated MAD2 haplo-insufficient mice developing lung 
tumors at high rates and respective cells displayed high levels of chromosomally instable 
aneuploid cells (Michel et al. 2001). Similarly, in mouse models reduced levels of CENP-E 
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and BubR1 have been reported to increase the frequency of aneuploidy and cause 
formation of spontaneous or induced tumors in vivo (Weaver et al. 2003; Dai et al. 2004; 
Weaver et al. 2007). Likewise, was found that MAD2 or BubR1 haploinsufficiency 
condition can induce aneuploidy and mitotic alterations in human primary fibroblasts 
(IMR90) and in near stable colon cancer cells (HCT116) (Lentini et al. 2012; Lentini et al. 
2014).  In human tumors, mutations in BUBR1 have been linked to induction of mosaic 
variegated aneuploidy (MVA), a rare disorder due to constitutional aneuploidy that 
predisposes these individuals to develop cancer (Hanks et al. 2004). Moreover, MVA 
patient-derived cell lines exhibit reduced BubR1 expression which was associated with low 
SAC activity and defects in chromosome alignment (Suijkerbuijk et al. 2010). 
Consequently, deregulation of SAC proteins in cancer cell lines can lead to incorrect 
chromosome segregation, which provides one potential explanation for the aneuploidy 
induction in cancer cells. 
1.2.1.2 Cohesion defects 
Sister chromatid cohesion defects result in chromosomal missegregation. During 
cell divisions, two newly replicated sister chromatids are kept together by conserved 
protein complexes called cohesins. This cohesin complex protects the sister chromatids 
from premature segregation which may result in aneuploidy and thus is implicated in 
control of genomic stability (Fig. 7B). The cohesin rings are cleaved by separase at 
anaphase onset. Sister chromatid cohesion is necessary to create tension by keeping the 
sister chromatids together while they are pulled by microtubules that depart from the two 
poles (Peters 2012). Inactivation of proteins working in the cohesion pathway, such as 
STAG2, has been reported to cause aneuploidy in human cells (Solomon et al. 2011). In 
line, separase levels were found to be increased in breast cancer tissues (Zhang et al. 2008) 
as well as other members of the cohesion pathway as for example WALP (Oikawa et al. 
2004) and securing (Zou et al. 1999). Furthermore, it was shown that sister chromatid 
cohesion is important to prevent merotelic attachment (Cimini 2008). 
1.2.1.3 Merotelic kinetochore-microtubules attachment  
The Spindle Assembly Checkpoint discriminates proper from improper 
kinetochore-micotubules attachment because proper attachment generates tension that 
results in intra-kinetochore stretching and this kinetochore state is unable to bind SAC 
proteins (Maresca & Salmon 2010). A particular type of improper attachment that is not 
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detected by the checkpoint is the merotelic attachment, in which the same kinetochore 
binds to microtubules from both poles. Merotelic attachments generate tension and are 
therefore not sensed as erroneous. This attachment defects result in lagging chromosomes 
(chromosomes that are not properly aligned) and consequently chromosome 
missegregation and aneuploidy (Fig. 7C) (Cimini et al. 2001). Several defects are found to 
generate merotelic attachments such as defects in condensin (Samoshkin et al. 2009), 
induction of multipolar spindles (Ganem et al. 2009) and hyper stable kinetochore-
microtubule interactions (Kabeche & Compton 2012). 
1.2.1.4 Multi-polar mitotic spindles 
The spindle poles contribute to the formation of a bipolar mitotic spindle in early 
mitosis. The centrosome forms the poles of the mitotic spindle and cells possessing extra 
centrosomes can form multipolar spindles. If not corrected, a multipolar anaphase can 
produce three or more highly aneuploid daughter cells that are likely to be inviable (Fig. 
7D). Defects involving centrosome changes in number, organization, and behavior, have 
been found in a variety of solid tumors (Brinkley 2001). However, multipolar mitotic 
divisions are rare because in most cases extra centrosomes are clustered into two groups 
allowing bipolar spindles to form. Nevertheless, in these cells merotelic attachments are 
frequent and the consequent lagging chromosomes cause low-level aneuploidy (Ganem et 
al. 2009). Interestingly, it was found that centrosome amplification alone is not sufficient 
to induce chromosomal instability in colon cancer cells with a MIN phenotype because 
clustered extra centrosomes form a pseudo bipolar spindle. To generate aneuploidy cells is 
necessary that centrosome amplification has to be associated to alterations in genes 
regulating mitosis progression such as Aurora-A/STK15 to trigger chromosomal instability 
(Lentini et al. 2007). 
Furthermore, experiments with cultured cells have shown that progression of 
mitosis in the presence of multiple spindle poles leads to defects in chromosome 
segregation (Ganem et al. 2009; Maiato & Logarinho 2014).  
1.2.1.5 Structural Aneuploidy 
Many aneuploid cells can display numerical aneuploidies but also structural 
aneuploidies due to mitotic mistakes (Janssen et al. 2011; Ganem & Pellman 2012). For 
example, the MAD2 overexpression in a mouse model led to the induction of loss or gain 
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of whole chromosomes, as well as caused structural defects in the chromosomes and 
initiated tumorigenesis (Sotillo et al. 2007). 
In aneuploid cells, the origin of these gross chromosomal rearrangements (GCRs) 
such as translocations, deletion of a chromosome arm, interstitial deletions or inversions, is 
mostly unclear. It is known that DNA damaging agents such as γ-irradiation and 
hydroxyurea induce chromosomal rearrangements suggesting that rearrangements might be 
a result of improper repair of DNA lesions (Suzuki et al. 2003). In addition, the prolonged 
mitotic arrest is also a source of DNA damage. For example, depletion of CENP-E by 
RNAi in colon cancer cells induces a transient mitotic arrest and DNA breaks (Dalton et al. 
2007).  
The presence of damaged DNA and chromosome breakage, or lagging 
chromosomes may result in the formation of aberrant nuclear structures called micronuclei 
after cell division (Cimini et al. 2001). Micronuclei can contain a chromosomal fragment 
or an entire chromosome. Replication of this trapped DNA is often defective and results in 
a pulverization of the chromosome which is later reassembled leading to structural 
aneuploidy (Crasta et al. 2012). In pRb-depleted primary human fibroblasts, that possess 
an intact spindle checkpoint, the generation of micronuclei is responsible of aneuploidy 
development (Amato et al. 2009). In these cells, pRb loss promotes aneuploidy mainly by 
inducing CENPA overexpression that in turn might induce micronuclei caused by mis-
attached kinetochores which could trigger chromosome segregation errors (Amato et al. 
2009). 
1.2.1.6  Polyploidy    
Polyploid cells are those containing more than two paired (homologous) sets of 
chromosomes. In other mammals, tetraploidy causes early lethality and spontaneous 
abortion or resorption of the embryo. In contrast, it is frequent in plants and many insects. 
In human it was observed that some kinds of cells are polyploid as megakaryocytes, 
hepatocytes, osteoclasts and skeletal muscle cells. However, polyploidy is even present in 
some cancer cells (Davoli & de Lange 2011). 
In tumors, the chromosome numbers are distributed into two peaks, one 
representing tumors that are near-diploid and one representing tumors with a chromosome 
number between a triploid and a tetraploid genome (Storchova & Kuffer 2008). This 
bimodal distribution underlines that aneuploidy in cancer cannot be explained with a single 
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mechanism underlying aneuploidy. To account for aneuploidy with high chromosome 
numbers it was proposed that these cancers originate from an unstable tetraploid 
intermediate (Shackney et al. 1989). Tetraploid cells are known to frequently missegregate 
chromosomes due to their supernumerary centrosomes (Ganem et al. 2009) and they will 
therefore readily generate subclones with the hypotetraploid or hypertriploid chromosome 
numbers observed in cancer. 
 At the molecular level several mechanisms have been found to facilitate induction 
of polyploidy: cell fusion, failure in cytokinesis or other steps in mitosis and endo-
reduplication. Cell fusion generates a bi-nucleate intermediate that can produce daughter 
cells with single 4N nuclei in G1. Experimentally induced fusion of primary human 
fibroblasts has been shown to enhance their in vitro transformation with potent oncogenes 
(Duelli et al. 2007). Several types of failure mitosis can give rise to a cell with double the 
chromosome number. In cells with MAD2 overexpression was observed induction of 
tetraploidy through cytokinesis failure (Sotillo et al. 2007). Furthermore, failure in 
cytokinesis is associated with overexpression of Aurora A, a kinase critical for mitosis 
(Zhang et al. 2004).  
Tetraploidization and its associated aneuploidy are particularly well-suited to 
accelerate tumor genome evolution because allow tumor cells to sustain a higher incidence 
of mutations thereby increasing the probability of adaptive changes (Davoli & de Lange 
2011).  
1.2.2 Proliferation and Physiology of Aneuploid Cells 
Maintenance of a balanced euploid genome is a key requisite for the success of all 
multicellular organisms. Possession of an equal number of each chromosome ensures a 
balanced genome where genes on different chromosomes are present in equal numbers. In 
contrast, aneuploidy, results in an unbalanced genome with different copy numbers for 
genes on different chromosomes. This is generally not well tolerated in nature. 
Aneuploidy that arises during gamete formation or during the early embryonic 
divisions results in entire organisms with an aberrant karyotype that is frequently lethal 
early in development. For example, in mouse all autosomal aneuploidies are embryonic 
lethal with the exception of Trisomy 19, which is the smallest mouse autosome and even 
these mice die shortly after birth. Even in human, the best-known and most studied 
organismal aneuploidy is the genetic condition responsible for Down syndrome (Trisomy 
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21) whose individuals display frequently stunted growth. Down syndrome individuals do, 
however, exhibit a decreased risk of solid tumors (Satgé et al. 2003). Two other trisomies 
survive to birth in humans; these are Trisomy 18 (Edwards syndrome) and Trisomy 13 
(Patau syndrome). Only approximately 10% of children born with these syndromes live to 
one year of age (Rasmussen et al. 2003). In summary, it is clear that aneuploidy causing 
growth retardation and developmental abnormalities in most organisms.  
It is not clear if the aneuploidy effects on cell physiology are due to the mere 
presence of additional DNA in the form of chromosomes or lack of chromosomes, or 
whether they are due to changes in gene expression levels. In some organisms aneuploid 
chromosomes are expressed according to gene copy number (e.g. yeast, MEFs and Down 
syndrome) while in other organisms (plants and Drosophila) exists a compensatory 
mechanisms that attempt to “balance out” gene copy number imbalances caused by 
aneuploidy (Torres et al. 2007; Williams et al. 2008; Mao et al. 2003; Larsson et al. 2004; 
Stenberg & Larsson 2011). It appears that species-specific differences exist in the ability to 
attenuate gene expression from aneuploid chromosomes, both at the RNA and protein 
levels, and these differences affect the aneuploid effects on cell physiology.  
1.2.2.1 General detrimental consequences of aneuploidy in the cells 
Beyond the effects of aneuploidy on gene expression, cellular studies have revealed 
that aneuploidy causes several general effects. These are largely detrimental and appear to 
be conserved across species but, in rare circumstances, were observed beneficial effects of 
aneuploidy. Among the key phenotypes shared by aneuploid cells is their slower 
proliferation compared to euploid cells. This effect was observed in aneuploid mouse 
embryonic fibroblasts (MEFs) trisomic for either chromosome 1, 13, 16, or 19 (Williams et 
al. 2008) that exhibit proliferation defects, as do cells harboring random aneuploidies 
caused by impaired SAC function. Also in primary human fibroblasts (IMR90), aneuploidy 
caused by MAD2 depletion triggers slowdown proliferation and activation of cellular 
senescence by the p53 pathway (Lentini et al. 2012).  
Beyond proliferation rates, aneuploid cells also exhibit a number of other 
phenotypes that can be broadly summarized as an “aneuploidy stress response” (Fig.8). 
The major effects of aneuploidy observed in cells are metabolic alterations, protein 
imbalance, genomic instability and death. Metabolic changes were found in MEF cultures 
containing the aneuploidy-inducing Cdc20
AAA
 mutation which exhibit increased glucose 
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uptake and increased production of lactate and reactive oxygen species which led to the 
activation of p53 through activation of ATM pathway (Li et al. 2010). In addition to 
energy stress, proteotoxic stress, i.e. physiological strain accrued from an abundance of 
misfolded proteins, is present in aneuploidy yeast cells (Torres et al. 2007). Evidence for 
proteotoxic stress also exists in aneuploid mammalian cells. Trisomic MEFs harbor 
increased rates of autophagy and increased basal levels of the inducible chaperone Hsp72 
(Tang et al. 2011). It is evident that aneuploid cells display marked growth defects, which 
are probably based on an increased need in energy due to transcription, translation and 
degradation of extra protein. 
Aneuploidy has been shown to increase genomic instability and the rate of 
chromosome missegregations that can results in DNA damage. Merotelically attached 
chromosomes, induced by compounds that interfere with mitotic spindle formation, remain 
in the center of the cell during anaphase and are broken during cytokinesis (Janssen et al. 
2011). Lagging chromosomes can also form micronuclei, which then experience 
substantial DNA damage during subsequent replication (Crasta et al. 2012). Janssen et al. 
found that lagging chromosomes suffer DNA damage during cytokinesis, which activates 
p53 through the ATM pathway while a second study using the same treatment found no 
evidence for DNA damage in lagging chromosomes but p53 was still activated and halted 
cell cycle progression through a p38 kinase dependent stress response, presumably 
triggered by aneuploidy-induced stresses such as metabolic alterations and protein 
imbalances (Thompson & Compton 2010). In conclusion, there is indication that aneuploid 
cells display a common aneuploidy specific cellular response, which may be conserved. 
However, this hypothesis is mainly based on correlative studies and detailed experiments 
elucidating underlying mechanisms are yet missing. 
 
CHAPTER 1: INTRODUCTION 
27 
 
 
Fig.8. Observed characteristics of aneuploidy in mammalian cells (Siegel & Amon 2012). 
1.2.2.2  “Beneficial” effects of aneuploidy 
Despite the clearly detrimental effects of aneuploidy on cellular fitness, this 
condition can, in rare cases of strong selective pressures, give cells a competitive edge. 
Potential beneficial effects of aneuploidy under extreme selective pressure have been 
observed in several systems. For example, in budding yeast, specific aneuploidies have 
been shown to provide resistance to toxic agents (Pavelka et al. 2010). In human 
fibroblasts, the introduction of an additional copy of chromosome 8 caused loss of contact 
inhibition, but cells still proliferated more slowly than  diploid cells (Nawata et al. 2011). 
Probably, aneuploidy can provide an effective means of quickly adapting to a selective 
pressure. However, this selective advantage comes at a price for the cells because changes 
in gene copy number of an entire chromosome induced by aneuploidy disrupt protein and 
energy homeostasis and cause proliferation defects in addition to chromosome specific 
detrimental effects. Naturally, in presence of mutations that mitigate the adverse effects of 
aneuploidy, the full adaptive and genome-instability inducing potential of aneuploidy 
comes into play as suggested by aneuploidy-tolerating mutations found in yeast (Torres et 
al. 2010). Loss of p53 also increases the proliferative abilities of aneuploid mammalian 
cells (Li et al. 2010; Thompson & Compton 2010; Janssen et al. 2011). Thus, identification 
of genetic alterations that ameliorate the adverse effects of aneuploidy could yield dramatic 
insight into tumorigenesis. 
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1.2.3 Aneuploidy and Chromosome Instability in Cancer 
Aneuploidy has been implicated in several diseases but the most striking correlation 
between aneuploidy and disease can be found in cancer. The occurrence of aneuploidy in 
cancer has long been known. David van Hansemann first noted that tumors have 
unbalanced mitoses over 120 years ago (Hansemann 1890). This work influenced Theodor 
Boveri to expand upon his earlier characterization of aneuploidies in sea urchins to suggest 
that a single aneuploid cell might cause cancer (Boveri 1914). More than ninety percent of 
solid tumors and seventy-five percent of blood cancers show some degree of aneuploidy 
(Weaver & Cleveland 2006). Many different types of chromosomal abnormalities are 
observed in cancer cells underlying the complexity and elusive relationship between 
aneuploidy and tumorigenesis. It is difficult assert if aneuploidy can promote cancer 
although cancer and aneuploidy cells show similar characteristics, like changes in 
metabolism or elevated proteotoxic stress and genomic instability (Hanahan & Weinberg 
2011). The situation is, however, not simple as “aneuploidy causes cancer” suggested by 
Boveri almost 100 years ago. It appears that aneuploidy sometimes promotes 
tumorigenesis, sometimes seems inconsequential, and sometimes inhibits disease initiation 
and progression.  
The major evidences that aneuploidy contributes to tumorigenesis comes from the 
study of animal models of chromosomal instability. Chromosomal instability (CIN) refers 
to an increased rate of chromosome missegregation due to errors in mitosis (Geigl et al. 
2008). There are many events leading to CIN: multipolar spindles, improper chromosome 
condensation or cohesion, defective mitotic checkpoint, improper kinetochore-
microtubules attachments etc. (Thompson et al. 2010). In mouse models, many studies 
refer a link between CIN and tumorigenesis and most of them are focused on partial 
inactivation of proteins which are involved in the spindle assembly checkpoint (SAC). 
Generally a weakened SAC results either in increased chromosome mis-alignments or in 
the inability to resolve them, thus leading to chromosome missegregation and subsequent 
formation of aneuploidy. Deletion of one copy of MAD2 induces aneuploidy in vitro and 
in vivo and leads to a high frequency of mice with papillary lung adenocarcinomas, a tumor 
that is extremely rare in wild-type mice (Michel et al. 2001). At the same time 
heterozygosis of MAD1, BubR1 or CENP-E increase constitutive tumors in mouse while 
overexpression of MAD2 or Bub1 induces CIN and cancer (Dai et al. 2004; Iwanaga et al. 
2007; Weaver et al. 2007; Sotillo et al. 2007; Sotillo et al. 2010; Ricke et al. 2011). Mice 
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with one Cdc20
AAA
 allele that cannot be inhibited by the SAC have an increased tumor 
incidence (Li et al. 2009). Similar results are observed when the SAC is hyper-activated by 
overexpression of the outer kinetochore component Hec1 (Diaz-Rodríguez et al. 2008) or 
by overexpressing the SAC kinase Bub1 (Ricke et al. 2011). Both result in aneuploidies in 
vitro and cause an increase in tumor incidence and alteration of tumor spectra in vivo.  In 
summary, both weakening and hyper-activating the SAC is sufficient to generate 
aneuploidy and to induce tumorigenesis.  
However, although tumorigenesis is elevated, this increase is modest in many cases, 
particularly in mice with loss-of-function mutations in SAC genes (e.g. only 20% of 
CENP-E
+/-
 mouse develop tumors (Weaver et al. 2007). Consistently, haploinsufficiency of 
Bub3 or Rae1 did not result in increased tumorigenesis and some mouse models even 
showed decreased tumor formation when challenged with carcinogens (Babu et al. 2003; 
Kalitsis et al. 2005). Furthermore, homozygous knockouts of CENP-E or of any other SAC 
signaling genes (MAD2, MAD1, BubR1 etc.) result in massive chromosome segregation 
defects and early embryonic lethality suggesting that the relationship between impaired 
SAC signaling, aneuploidy and tumor onset is complex (Giam & Rancati 2015). Indeed, 
aneuploidy can also act as a tumor suppressor. Aneuploidy induced by the loss of one copy 
of CENP-E inhibited tumorigenesis in some tissues.  Furthermore, introducing additional 
aneuploidy can prevent tumorigenesis, presumably by inducing sufficient levels of 
aneuploidy to cause cell death (Weaver et al. 2007; Silk et al. 2013). At the same time 
simultaneous reduction of MAD2 and BubR1 expression induces elevate rate of 
aneuploidy and mitotic alterations that result in p53 dependent cell cycle arrest of tumor 
cells (Lentini et al. 2014). 
The observation that aneuploidy has been associated with defective development 
and lethality in multicellular organisms (Siegel & Amon 2012) and that, in mice and 
humans, all autosomal monosomies and almost all trisomies result in embryonic lethality 
reinforce the idea that aneuploidy alone may not induce tumorigenesis. Moreover, 
individuals with trisomy 21 have a lower likelihood of developing solid tumors (Hasle et 
al. 2000; Satgé et al. 2003), as do mouse models of the disease. However, since cancer 
genomes are highly complex and contain additional mutations besides chromosome copy 
number changes, it remains controversial whether aneuploidy acts as a driving force or as a 
foe of tumorigenesis.  
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1.3 THE IMPORTANCE OF GENETIC BACKGROUND IN 
ANEUPLOIDY 
As described in the previous sections, aneuploidy hinders cell proliferation in most 
cases and hardly any direct effects of aneuploidy are enough to induce tumorigenesis. At 
the same time the aneuploidy induced by haploinsufficiency of SAC genes has mixed 
effects on the development of tumors in mouse models (see paragraph 2.3). These 
observations can be explained by different options: 1. Aneuploidy is a consequence of CIN 
and the degree of CIN frequently correlates with karyotypic complexity. 2. SAC genes 
have other non-mitotic functions that make it difficult to dissect which function is 
associated to increased cancer susceptibility. 3. Aneuploidy has been implicated in several 
diseases but the most striking correlation between aneuploidy and disease can be found in 
cancer. aneuploidy needed additional oncogenic mutations (such as presence of oncogenes 
or inactivation of tumor-suppressor genes) (Giam & Rancati 2015).  
It has been suggested that the range in severity of the phenotypes observed in cells 
with CIN differs depending on the number of processes that will be affected when such a 
mutation is incurred. If mutating a factor only affects one cellular process that promotes 
tumorigenesis, the effect will be less severe than if multiple tumor-promoting pathways are 
affected by a single alteration (Ricke et al. 2008). 
1.3.1 INK4/ARF locus 
The human INK4/ARF (CDKN2A) locus, located on human chromosome 9q21, 
encodes two completely unrelated proteins p16
INK4a
 and p14
ARF
 (p19
ARF
 in mouse), both 
potent inhibitors of cell proliferation. The mechanism by which these two proteins are 
produced is quite unusual: each transcript has a specific 5’ exon, E1α or E1β for p16INK4a 
and p14
ARF
 respectively, which are spliced to a common exon 2. This exon contains two 
overlapped ORFs, therefore the two proteins encoded share no amino acid sequence 
identity (Fig.9) (Quelle et al. 1995). The alpha transcript encoding p16
INK4a
 was the first to 
be identified so the protein produced by the alternative beta transcript was named ARF, 
where ARF stands for Alternative Reading Frame. In addition, it has been found in the 
CDKN2a locus the presence of the INK4b gene (also known as CDKN2B) that is 
generated from the tandem duplication of INK4 gene and encodes the kinase inhibitor 
p15
INK4b
 (Sharpless & DePinho 1999). Both proteins interact and inhibit the kinase activity 
of cyclin dependent kinases 4 and 6 (CDKs) which in turn affect the pRb pathway and led 
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to E2F repression and growth arrest. The binding with p16
INK4a
 and p15 
INK4b
 prevents the 
interaction of the CDKs 4 and 6 with the D-Cyclins, required for their catalytic activity and 
for the cell cycle progression from G1 to S phase (Russo et al. 1998; Serrano et al. 1993; 
Sherr 2006). 
The β transcript results in a polypeptide of 132 amino acids and 14 kDa named 
p14
ARF
 and regulates the induction of cell cycle arrest and/or apoptosis by p53-dependent 
and independent pathways (Ozenne et al. 2010; Sherr 2006). Under normal conditions, the 
p14
ARF
 gene (and the other genes in the locus) is repressed by the action of Polycomb 
proteins (PcG), which inhibit the expression of specific genes by chromatin modifications. 
BMI (B lymphoma Mo-MLV insertion region 1) is one of the main PcG components that 
repress p14
ARF 
expression.  In fact, murine embryonic fibroblasts (MEFs) BMI-1
-/-
 show a 
detected upregulation of the expression of p14
ARF
 and p16
INK4a
 (Jacobs et al. 1999). The 
gene silencing PcG-mediated is also the molecular mechanism by which the p53 tumor 
suppressor represses the p14
ARF
 expression. Indeed, p53 binds the promoter of p14
ARF
 and 
recruits the complex histone deacetylation (HDAC) and PcG proteins (Zeng et al. 2011).  
p14
ARF
 transcription is upregulated in response to a host of oncogenic signals 
including c-Myc, Ras, E2F-1, E1A, and v-Abl to induce cell cycle arrest (Sherr 2001). 
Interestingly, Ras-induced ARF-mediate cell cycle arrest is not immediate. Wild-type 
MEFs transduced with oncogenic RasV12 accumulate ARF protein over time and do not 
succumb to ARF-mediated cell cycle arrest for approximately 5 days. This data suggests 
that a threshold level of ARF protein must accumulate before cell cycle arrest can be 
achieved (Groth et al. 2000). 
Since p14
ARF
 is normally activated as a result of oncogenic signals to stabilize p53 
tumor suppressor and p16
INK4a
 or p15
INK4b
 proteins are involved in cellular pathways 
controlled by pRB, it is intuitive to think that mutations that fall in a common region of 
exon 2 can alter simultaneously two pathways that have a synergistic effect on the control 
and block cell proliferation (Sharpless 2005). Mutations within exon 2 that affect both 
p14
ARF
 and p16
Ink4a
 are found in many cancers (del Arroyo & Peters 2005; Gardie et al. 
1998).  
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Fig.9. INK4/ARF locus. 
1.3.2 p14ARF Tumor Suppressor and Cancer  
The genes in the INK4/ARF locus are frequently mutated or silenced in cancer cells 
since they encode proteins that prevent tumorigenesis (Fig.9). A direct contribution of 
p14
ARF
 to tumor formation has been documented using genetic analysis of tumors, 
molecular and cell biology methods and animal models (Muniz et al. 2011; Shimizu et al. 
2010). It has been reported that ARF-null mice are highly cancer prone. Particularly, ARF 
knock out mice die after 1 year from spontaneous tumor development. Moreover, 
heterozygous mice also develop tumors after a longer latency than ARF-null mice (Maggi 
et al. 2014). Although alterations of INK4a-ARF locus are not common in humans, they 
were found in roughly 30% of human tumors such as glioblastoma, melanoma, pancreatic 
adenocarcinoma (Maggi et al. 2014; Sherr 1998; Sharpless & DePinho 1999). In most 
cases of human cancer, all three proteins of the IINK4/ARF locus are lost, making it 
difficult to determine their individual roles in human tumor suppression. However, there 
are specific examples in which only p14
ARF
 appears to be affected in human cancer, and 
these cases appear to be most common in melanoma patients. Gene deletions in families 
with melanoma neural system tumor syndrome occur specifically in exon 1β (Randerson-
Moor et al. 2001). It has also described many p14
ARF
-specific alterations in other cancers 
as Barrett's adenocarcinoma, breast cancer, colorectal carcinoma, epithelial ovarian, gastric 
cancer, osteosarcoma and etc. (Maggi et al. 2014). Furthermore, the p14
ARF
 promoter 
contains a CpG island, and p14
ARF
 expression is consequently downregulated by promoter 
methylation (Robertson & Jones 1998; Zheng et al. 2000; Gonzalez & Serrano 2006). 
Taken together, these evidences clearly demonstrate the importance of p14
ARF
 tumor 
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suppression in human cancers. Because of the multiple roles played by p14
ARF
 protein, it is 
conceivable to think that the alteration of its functions have a key role in the development 
of tumors.  
1.3.3  p53-dependent p14ARF tumor suppression 
One of the most well defined function of p14
ARF
 protein is to suppress aberrant cell 
growth in response to oncogene insults by activating the transcription factor p53 that 
trigger the expression of many apoptosis inducers and cell cycle inhibitory genes (Ozenne 
et al. 2010). Among the many proteins counteracting genomic instability by ensuring 
genome surveillance and maintenance is the tumor suppressor p53, nicknamed the 
“Guardian of the Genome” (Vousden & Lane 2007). p53 critically determines the fate of 
cells experiencing DNA damage, activating cell cycle arrest, senescence or apoptosis 
depending on the severity of the insult (Bieging et al. 2014). TP53 is mutated in 
approximately half of all human cancers and the frequently genetic alterations are missense 
mutations that disrupt p53's ability to act as a transcriptional activator (Kato et al. 2003; 
Junttila & Evan 2009). It is well known that p53, for its important role, is subjected to 
stringent multi-level regulation. It has been widely reported that MDM2 (or HDM2) 
interacts with p53, blocks p53-mediated transactivation and, thanks to its E3 ubiquitin 
ligase function, targets the p53 protein for rapid degradation (Chen et al. 1995; Kubbutat et 
al. 1997; Levine 1997). Furthermore, p53 itself stimulates the transcription of MDM2 
binding its promoter; these determines the activation of a negative feedback system of p53 
shutting down (Marine & Lozano 2010).  
In this regulation pathway of p53 is involved p14
ARF
 protein. In presence of 
oncogenic stimuli p14
ARF
 binds the C-terminal domain of MDM2 and keep it in the 
nucleolus where usually resides p14
ARF
 because it has a specific amino acid sequence 
called NOLS. This event prevents the interaction between MDM2 and p53 and the 
transport in the cytoplasm of p53 and degradation MDM2-mediated (Pomerantz et al. 
1998; Weber et al. 1999; Ozenne et al. 2010).  By using deletion mutants of p14
ARF
 protein 
(able or not to localize to the nucleolus) it has been shown that both binding to MDM2 and 
the localization of p14
ARF
 protein in the nucleolus are necessary for p14
ARF
-induced p53 
stabilization, p53 activation and cell cycle arrest. In particular, the interaction between 
p14
ARF
 and MDM2 sequestered MDM2 in the granular region of the nucleolus (Weber et 
al. 2000). Also p14
ARF
 is able to inhibit the ARF-BP1/Mule protein, another E3 ubiquitin 
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ligase that targets p53 (Chen et al. 2005). A study highlights the importance of p14
ARF
 in 
p53's tumor suppressive role in response to oncogenic stimuli using mice with an extra 
copy of p53 (“supra p53” mouse) that are completely protected from oncogenic stress-
induced tumorigenesis. However, this protection is completely abrogated in ARF-deficient 
“supra p53” mice (Efeyan et al. 2006). Keeping in mind that p14ARF transcription is 
negatively regulated by p53, yet another negative feedback loop exists to limit p53 
activation.  
In addition to the known function of MDM2 regulation by p14
ARF
, a recent study 
describes a new mechanism through which MDM2 can in turn regulate p14
ARF
 levels 
during the tumorigenic process. It was shown that MDM2 overexpression in various cancer 
cell lines causes p14
ARF
 reduction inducing its degradation through the proteasome thanks 
to p14
ARF
 phosphorylation PKC-mediated (Vivo et al. 2015).  
1.3.4 p53-indipendent function of p14ARF 
Although p14
ARF
 is undoubtedly a critical component of the p53 pathway, there are 
some evidences that p14
ARF
 has also the ability to restrain cell growth independently of 
p53. Mice lacking ARF, p53 and MDM2 are more tumor prone that those lacking only p53 
and MDM2. Furthermore, ARF
-/-
 and ARF
+/-
 mice develop a broader spectrum of tumors 
than p53-null mice (Weber et al. 2000). In line with this Weber and colleagues (2000) 
showed that ARF overexpression can induces a G1 arrest in cells lacking p53. In particular, 
in cells deficient for ARF/p53/MDM2 (derived from triple knockout or TKO mice), they 
observed that the reintroduction of wild type ARF was able to prevent S phase entry and/or 
trigger apoptosis by mechanisms that did not require the expression of wild-type p53 
protein. They also demonstrated a significant reduction of colony formation in ARF 
infected TKO mice. Moreover, it has also been reported that p14
ARF
 induces cell cycle 
arrest in a p53-independent manner in human lung tumor cells (Eymin et al. 2003). In 
particular, p14
ARF 
expression determined a G2 arrest followed by apoptosis both in ‘‘in 
vitro’’ and ‘‘in vivo’’ models. In this latter case, upon p14ARF overexpression a decrease of 
tumor growth and induction of lung tumors regression was observed in xenograft models. 
Other studies support the idea that p14
ARF
 also stimulates important pathways to 
maintain the genomics integrity and stability. In fact, in response to DNA damage caused 
by ionizing radiation, UV and genotoxic treatments, p14
ARF
 intervenes either through a 
p53-dependent that p53-indipedent pathways. Together with p53, activated by kinases 
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ATM and ATR, it can induce cell cycle arrest and possibly apoptosis. However, it was 
seen that the activation of ATM/ATR signaling cascade may be upstream triggered from 
p14
ARF
 protein which stabilizes the Tip60 protein, a histone acetyltransferase that activates 
ATM by acetylation (Eymin et al. 2006). Taken together these results support a role of 
p14
ARF
 in mediating p53- independent tumor suppressive functions and suggest that p14
ARF
 
also acts independently of the MDM2-p53 axis in tumor surveillance. 
In line with this, it has been reported that p14
ARF
 can interacts with a multitude of 
different cellular partners: proteins involved in transcriptional control (E2Fs, DP1, p63, c-
Myc, Hif1α), nucleolar proteins such as nucleophosmin (NPM/B23), viral proteins (HIV-
1Tat), mitochondrial protein (p32) and many others (Sherr 2006). The variety of the p14
ARF
 
interactors strongly suggested that p14
ARF
 has a wider role to protect the cell upon different 
types of insults. For example p14
ARF
 interacts and antagonizes the transcriptional functions 
of Myc and E2F1, powerful oncogenes required for cell cycle progression, inducing their 
capture in the nucleolus or preventing the recruitment of their transcriptional coactivators 
(Eymin et al. 2001). Instead, other p14
ARF
 partners like B23/NPM are degraded by the 
proteasome in an ubiquitin-dependent manner or few others like Tip60 or TOPO I become 
activated or stabilized (Pollice et al. 2008). 
In addition, it has been described that p14
ARF
 is able to promote sumoylation of 
some of its interactors. This modification can affects an high variety of phenomena such as 
protein stability, transport, modulation of gene expression (up-regulation or down-
regulation), ubiquitination, DNA repair, and centromeric chromatid cohesion(Tago et al. 
2005; Ozenne et al. 2010). In particular, it has been reported that p14
ARF
 interacts with the 
Myc-associated zinc finger protein Miz1 and, by inducing its sumoylation, facilitates the 
assembly of the Myc-Miz1 complex that cause the switch from G1 arrest to apoptosis 
(Herkert et al. 2010). It has been shown that p14
ARF
 can induce sumoylation of both 
MDM2 and nucleophosmin NPM/B23 (Maggi et al. 2014). Although the precise 
mechanism underlying this p14
ARF
 function is currently unknown it has been suggested 
that it explicates this function through a direct interaction with the sumo-conjugating 
enzyme Ubc9. Additionally, p14
ARF
 also inhibits the function of a de-sumoylating protein, 
SENP3 (Haindl et al. 2008). Although p14
ARF
 involvement in the sumoylation process is 
well documented, the biological meaning of p14
ARF
 mediated sumoylation is still unclear. 
As p14
ARF
 is mainly localized in the nucleolus this led to the hypothesis that it 
might play a role in the ribosomal biogenesis (Saporita et al. 2007). In fact, there are data 
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that show inhibition of rRNA processing following the downregulation of NPM mRNA. In 
addition, it has been shown by blocking NPM nucleo-cytoplasmic shuttling that p14
ARF
 is 
able to interfere with the ribosome export resulting in a delayed rRNA transcription and 
processing (Itahana et al. 2003; Sherr 2006). 
1.3.5 Role of Tumor Suppressors in Aneuploidy 
As discussed above SAC weakening is sufficient to generate aneuploidy. However 
it has been demonstrated that aneuploidy have deleterious effects on cellular fitness in both 
yeast and mammalian cells (Torres et al. 2007; Siegel & Amon 2012). The aneuploidy 
induced by SAC gene alteration, in many case, generates a modest increase of 
tumorigenesis because the cell active control pathways to limit aneuploidy proliferation. 
For example, MAD2 depletion generate aneuploidy in primary human fibroblasts that 
active a senescence cellular pathway p53/p21-mediated (Lentini et al. 2012). This anti-
proliferative effect can be mitigated by genetic alterations that allow cells to tolerate the 
adverse effects of aneuploidy, and by mutating genes that restrict proliferation of aneuploid 
cells, such as p53. Two of the most recurrent cytogenetic abnormalities observed among 
different types of cancers were gain of chromosome 8q (encoding the MYC oncogene) and 
loss of 17p (where is localized the TP53 tumor suppressor gene) suggesting that 
aneuploidy could underlie transformation by amplification of oncogenes or loss of tumor 
suppressors (Nicholson & Cimini 2013).   
In support of this hypothesis, it was observed that aneuploidy caused by MAD1 or 
MAD2 depletion enhances tumorigenesis of cells with a genetic background p53
-/- 
(Holland & Cleveland 2009). However, loss of p53 allows highly aneuploid cells to 
proliferate in vitro (Li et al. 2010; Thompson & Compton 2010; Janssen et al. 2011), but 
does not directly cause euploid cells to become aneuploid (Bunz et al. 2002). At the same 
time, CENP-E heterozygous and p19/ARF null mice developed much more easily and with 
greater frequency spontaneous tumors compared to mice heterozygous for CENP-E but 
p19ARF wt (Weaver et al. 2007).  Perhaps, loss of a tumor suppressor such as p53 is a 
prerequisite for the development of aneuploidy in human tumors, or an event required 
immediately after aneuploidy induction to promote tolerance to the aneuploid state. 
However the relationship between aneuploidy, CIN and tumorigenesis is not so 
simple. It was proposed that a moderately elevated rate of CIN could potentially allow 
transformation while too much or too little CIN would have no effect or even inhibit the 
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carcinogenesis process (Weaver & Cleveland 2007).  Silk et al. showed that exacerbating 
the level of CIN in CENP-E
+/−
mice by crossing them to MAD2
+/−
 or p19ARF
−/−
 mice or by 
treating them with the chemical carcinogen DMBA resulted in enhanced cell death and 
reduced tumor incidence (Silk et al. 2013). A possible explanation of these observations is 
that eukaryotic cells have acquired surveillance mechanisms that actively prevent the 
propagation of highly aneuploid cells (Giam & Rancati 2015).  In this case, while too 
much CIN could activate these protection mechanisms and target the cell to death or arrest, 
a moderate level of CIN might allow aberrant cells to keep proliferating. Accordingly, the 
tumor suppressor p53 is upregulated upon aneuploidization and has been shown to limit 
the proliferation of aneuploid cells in culture (Thompson & Compton 2010; Li et al. 2010; 
Lentini et al. 2012; Veneziano et al. 2016). A possible stress pathway that could play a role 
is the p38/p53 pathway that limits proliferation of aneuploid cells (Thompson & Compton 
2010).  Recently, alternative pathways were proposed to reduce proliferation of aneuploid 
cells through activation of p14
ARF
/p53 apoptosis or cellular senescence p53/p21 mediated 
(Veneziano et al. 2016; Lentini et al. 2012). These results suggested that p14
ARF
 could be a 
potential target that aneuploid cells use to overcome restriction mechanisms of cell 
proliferation. Further data showed that p14
ARF
 is involved in the control of genomic 
stability in p53
-/- 
cells; p53
-/-
 MEFs and also ARF
-/-
 MEFs and ARF
-/-
/p53
-/- 
double 
knockout MEFs had defects in chromosome segregations that were restored by p14
ARF
 
with the cooperation of Aurora B (Britigan et al. 2014). 
In summary, CIN and aneuploidy have tumor-promoting abilities that are limited 
by anti-proliferative effects associated with aneuploidy. When these anti-proliferative 
effects are suppressed through aneuploidy-tolerating mutations, such as tumor suppressor 
genes, the full tumorigenic potential of the condition is unleashed.  
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CHAPTER 2: AIM OF RESEARCH 
The alteration of the Spindle Assembly Checkpoint genes can lead to errors in 
chromosome segregations (CIN) and aneuploidy. These chromosome numeric aberrations 
are commonly observed in human cancer. Many studies described that the alteration of 
SAC genes is  involved in aneuploidy generation and that this process can be implicated in 
tumorigenesis (Giam & Rancati 2015). However, it was also observed that aneuploidy is 
better tolerated in cells that show alteration in tumor suppressor genes (Siegel & Amon 
2012). Consequently, it is important to understand which genes and pathway are normally 
involved to prevent the aneuploidy proliferation. 
At the same time, Weaver’s group suggested a new role of p14ARF in the control of 
aneuploidy in MEFs, where the tumor suppressor gene limits aneuploidy in a way p53-
indipendent with Aurora B collaboration (Britigan et al. 2014; Silk et al. 2013).  
In this study, I wanted to investigate the relationship between some of the SAC 
genes, that if depleted induce aneuploidy, and tumor suppressor genes. My aim was, first, 
to investigate the role of p14
ARF
 in counteracting aneuploidy by inducing its ectopically 
expression in HCT116 cells, in which p14
ARF
 is not functional because of mutations in 
both the alleles (promoter hypermethylation and gene mutation) (Burri et al. 2001), after 
MAD2 depletion. I evaluated the level of aneuploidy and mitotic alterations in cells 
expressing or not expressing p14
ARF
 and the possible pathway(s) (cellular senescence or 
apoptosis) and gene partners activated by p14
ARF
 to limit aneuploidy. I used post-
transcriptional silencing of CENP-E, which works only in the SAC signaling, to induce 
aneuploidy in HCT116 cells and in IMR90 cells to investigate the involvement of p14
ARF
 
on aneuploid cell proliferations. To refine these results, I generate HCT116 cells 
expressing a functional p14
ARF
 to assess the ability of p14
ARF
 to counteract aneuploidy 
induced by CENP-E depletion. 
 Determination of pathways that are deregulated in all aneuploid cells will lead to 
further research analyzing common patterns of genes involved in the maintaining of 
aneuploidy. Identifying these differences is crucial for understanding the impact of 
aneuploidy on tumorigenesis. 
 
 
CHAPTER 3: RESULTS 
39 
 
CHAPTER 3: RESULTS 
3.1 p14ARF PREVENTS PROLIFERATION OF ANEUPLOID CELLS 
BY INDUCING p53-DEPENDENT APOPTOSIS 
Aneuploidy could potentially increase the risk of neoplastic transformation but it 
seems that this process occur when it is associated with mutations of tumor suppressor 
genes. Previously, it has suggested that p14
ARF
 could be one of the genes able to counteract 
the development of aneuploid cells (Lentini et al. 2012). In fact, aneuploidy caused by 
MAD2 haploinsufficiency activated a p53-dependent senescence pathway in IMR90 
human fibroblasts to counteract aneuploidy deleterious effects. On the contrary, aneuploidy 
promoted by MAD2 post-transcriptional silencing appeared to be well tolerated in 
MCF10A epithelial cells where the ARF gene coding for p14
ARF
 is deleted (Lentini et al. 
2012). In addition, it was shown that primary human fibroblasts (IMR90) perceived 
DNMT1 absence that would result in DNA hypomethylation, as a stress signal that 
activated a p14
ARF
/p53 pathway inducing G1 arrest. When this pathway was not working, 
cells progressed incorrectly in the cell cycle with altered DNA methylation 
(hypomethylation) that affected chromosomal segregation thus resulting in aneuploidy 
(Barra et al. 2012).  
To investigate further the putative role of p14
ARF
 dysfunction in aneuploid 
tolerance, I used as a system model near diploid HCT116 cells in which p14
ARF
 is not 
functional (Burri et al. 2001). I expressed ectopically the ARF gene in these cells where 
depletion of MAD2 by RNAi triggered aneuploidy and visualized that p14
ARF
 ectopic 
expression induced p53-dependent apoptosis of aneuploid cells. 
 
3.1.1 Ectopic expression of p14ARF in MAD2 post-transcriptional silenced 
HCT116 cells induced slowing down of proliferation  
To understand if p14
ARF
 is able to counteract aneuploidy caused by MAD2 
haploinsufficiency, p14
ARF
 was ectopically expressed in HCT116 cells that have one 
p14
ARF
 allele mutated and the other allele is silenced by DNA hypermethylation of the 
promoter (Burri et al. 2001). HCT116 cells were chosen because they are an established 
near-diploid cell line that maintains a stable karyotype (Lengauer et al. 1997). In order to 
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mimic MAD2 haploinsufficiency, I utilized the RNA interference strategy by using two 
different small interfering RNA (siRNAs) targeting the MAD2 transcript (siMAD2 #1, 
siMAD2 #2). Real-time qRT-PCR analysis showed that the siMAD2 #1 was able to reduce 
the amount of MAD2 transcript just about 50%. Thus, I decided to conduct all subsequent 
experiments using the siMAD2#1 (Fig. 10 A). Western blot experiments confirmed that 
RNA interference reduced to about 50% the MAD2 protein in HCT116 transfected cells 
(Fig. 10 B). 
 
 
 
Fig.10. p14ARF ectopic expression and MAD2 post-transcriptional silencing in HCT116 cells. 
A: Real Time RT-PCR analysis showing RNA interference of siMAD2 #2, siMAD2 #1 and siMAD2-
scramble at 72 h after transfection. B: Western Blot analysis at 72 h post transfection showing that RNA 
interference induced the reduction of MAD2 protein level in siMAD2 (2) and siMAD2/pcDNA3.1-p14 (4) 
HCT116 cells in comparison to WT (1) and pcDNA3.1-p14 (3) HCT116 cells, below the WB panel is 
showed the densitometry analysis to quantitate the MAD2 protein as normalized to β-Tubulin. C: Western 
blot analysis confirmed p14ARF protein increase 72 h after pcDNA3.1-p14 plasmid transient transfection in 
HCT116 pcDNA3.1-p14 (1) and HCT116 siMAD2/pcDNA3.1-p14 (2) compared to HCT116 pcDNA3.1 (3) 
and HCT116 siMAD2 (4); the graph above shows p14
ARF
 protein levels normalized to β-Tubulin. 
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To express ectopically p14
ARF
, HCT116 cells were transfected with the plasmid 
pcDNA3.1 carrying the p14
ARF
 c-DNA (Ayrault et al. 2006). By Western blot analysis, the 
p14
ARF
 expression was confirmed in all samples transfected with the pcDNA3.1-p14 
plasmid when compared to WT-HCT116 cells. Early effects of p14
ARF 
ectopic expression 
and MAD2 depletion were estimated by evaluating the cellular density/dish 48 h and 72 h 
post-transfection. While there were no statistically significant differences in proliferation 
between cells transfected with siMAD2 and siMAD2-scramble siRNAs, ectopic expression 
of p14
ARF
 induced a decrease of cell number in MAD2 silenced cells, as displayed by 
microscopic observation (Fig. 11 A). This result seems to be caused by p14
ARF
 ectopic 
expression, since cells transfected with control cells (siMAD2 scramble/ pcDNA3.1-p14 or 
siMAD2/pcDNA3.1) did not show reduction in cell numbers at 72 h post transfection (Fig. 
11 B and C). 
 
 
Fig.11. p14
ARF
 ectopic expression reduces proliferation of MAD2-depleted HCT116 cells. A: 
Pictures showing the cell density/dish of siMAD2 and siMAD2/pcDNA3.1-p14 HCT116 cells at 0 and 72 h. 
B: The graph shows HCT116 cell proliferation at 0, 48, and 72 h after transfection of siRNA targeting MAD2 
transcript (siMAD2), scrambled-siMAD2, and pcDNA3.1, pcDNA3.1-p14. C: The graph shows cell 
proliferation of siMAD2/pcDNA3.1, siMAD2/pcDNA3.1-p14, and siMAD2 scramble/pcDNA3.1-p14 
HCT116 cells at 0, 48, and 72 h post transfection. The experiment was repeated twice. (Student’s t-test * 
P<0.05; ** P<0.01, n=50). 
. 
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3.1.2 Ectopic expression of p14ARF reduced aneuploid cells and mitotic 
abnormalities caused by MAD2 depletion 
In agreement with previous reports (Thompson & Compton 2010; Lentini et al. 
2012) analysis of mitotic cells by cytogenetics revealed the presence of more than 90% of 
aneuploid cells after partial depletion of MAD2. The majorities (75%) of these mitotic 
cells were hypodiploid and only 16% were hyperdiploid (Fig. 12 A). Thus, weakening the 
SAC by MAD2 depletion induced aneuploidy in near diploid HCT116 cells. Previously, it 
was suggested that p14
ARF
 could play some roles in aneuploidy (Barra et al. 2012; Silk et 
al. 2013). To get additional clues on this aspect I estimated aneuploidy in HCT116 cells 
depleted of MAD2 and with transient expression of ectopic p14
ARF
. Both in siMAD2-
scramble and in pcDNA3.1-p14 HCT116 cells the aneuploidy level changed slightly in 
comparison to control. As expected the number of aneuploid cells dropped to 60% (56% 
hypodiploid and 4% hyperdiploid) after transient expression of ectopic p14
ARF
 in MAD2-
depleted HCT116 cells. On the contrary, MAD2-depleted HCT116 cells and then 
transfected with the pcDNA3.1-empty vector still showed a high percentage of aneuploid 
cells (79%) similar to that shown by cells transfected with siMAD2 alone (Fig. 12 A). 
Since aneuploidy may be associated with aberrant mitosis, I evaluated the presence 
of mitotic spindle alterations after p14
ARF
 ectopic expression and MAD2 depletion in 
HCT116 cells. Detection of b-tubulin of cells in mitosis revealed mitotic alterations as 
follows: monopolar spindles, all/ few chromosome outside of the spindle, and wrong 
orientation of the spindle. These altered mitosis were especially found in MAD2-depleted 
HCT116 cells (61%), and were reduced (40%) when p14
ARF
 was ectopically expressed 
(Fig. 3 B and C). These results are similar to those reported by the Weaver group where 
haploinsufficiency of CENP-E, induced mitotic spindle alterations (Silk et al. 2013). The 
finding that the percentage of altered metaphases is reduced in cells re-expressing p14
ARF
 
in comparison to HCT116 siMAD2/pcDNA3.1, suggested that p14
ARF 
re-expression 
promotes the elimination of aneuploid cells caused by MAD2 depletion (Fig. 12 B and C). 
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Fig.12. Aneuploidy and mitotic alteration are reduced in HCT116 siMAD2 cells following 
p14
ARF
 ectopic expression. A: Representative pictures of aneuploid metaphases (left) found in siMAD2, 
siMAD2/pcDNA3.1-p14 HCT116 cells and euploid metaphases of pcDNA3.1, and siMAD2 scramble 
HCT116 cells (right). On the right the graph showing the percentages of aneuploid cells in HCT116 
pcDNA3.1 (1) (Mitotic Index (MI):15), siMAD2-scramble (2) (MI:14), pcDNA3.1-p14 (3) (MI:13), 
siMAD2-scramble/pcDNA3.1-p14 (4) (MI:13), siMAD2 (5) (MI:6), siMAD2/pcDNA3.1 (6) (MI:11), and 
siMAD2/pcDNA3.1-p14 (7) (MI:9). B: On the right representative images of mitotic alterations detected by 
b-tubulin staining in all samples analyzed (DNA was stained with DAPI); on the left the percentages of 
normal and altered metaphases in pcDNA3.1 (1), siMAD2-scramble (2), pcDNA3.1-p14 (3), siMAD2-
scramble/pcDNA-p14 (4), siMAD2 (5), siMAD2/pcDNA3.1 (6), and siMAD2/ pcDNA3.1-p14 (7) HCT116 
cells. C: The graph summarizes the percentages of specific mitotic spindle alterations detected. All 
experiments were repeated at least twice. (Student’s t-test * P<0.05; ** P<0.01, n=50 metaphases). 
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3.1.3 p14ARF ectopic expression induces apoptosis and not premature cellular 
senescence in aneuploid cells 
Previously, it was shown that post-transcriptional silencing of MAD2 and DNMT1 
genes induced aneuploidy in human primary fibroblasts followed by premature cellular 
senescence, mediated by p14
ARF
, as a possible way to block aneuploid cells (Barra et al. 
2012; Lentini et al. 2012). Consequently, I investigated whether p14
ARF
 could activate the 
senescence pathway after MAD2 depletion in HCT116 cells. To this aim I conducted a 
senescence-associated -galactosidase (-gal) activity assay to evaluate the percentages of 
senescent cells after p14
ARF
 ectopic expression in MAD2 depleted cells. This assay was 
carried out at two different pH values: at pH6 only senescent cells were stained in blue 
while at pH4, used as a control, both senescent cells and proliferative cells were stained in 
blue. I found low percentages of -gal positive cells in all samples analyzed (Fig. 13), 
suggesting that in MAD2-depleted HCT116 cells ectopic expression of p14
ARF
 does not 
activate a cellular senescence pathway. 
 
Fig.13. p14
ARF
 does not induce cellular senescence in MAD2-depleted cells. On the left 
representative pictures of pcDNA3.1, siMAD2, and/or pcDNA3.1-p14 HCT116 cells, 72 h after transfection 
stained for -gal (pH4: young and senescent cells, pH6: senescent cells). The graph on the right summarizes 
the percentage of senescent HCT116 cells (-gal positive): pcDNA3.1 (1), siMAD2 (2), pcDNA3.1-p14 (3), 
and siMAD2/ pcDNA3.1-p14 (4). The differences are not statistical significant. 
 
Following simultaneous p14
ARF
 ectopic expression and siMAD2 post-
transcriptional silencing, I found the presence of many floating cells (data not shown). To 
assess if apoptosis was responsible for these floating cells, I conducted the Acridine 
Orange/Ethidium Bromide (AO/EB) assay that distinguishes live cells from apoptotic and 
CHAPTER 3: RESULTS 
45 
 
necrotic cells (Fig. 14 A). I found a high percentage of apoptotic (36%) and necrotic cells 
(17%) following p14
ARF
 ectopic expression and MAD2 depletion. By applying the 
Student’s t-test, these percentages of apoptotic and necrotic cells were statistically 
significant in comparison to the percentages found in siMAD2/pcDNA3.1 (22% apoptotic 
and 6% necrotic) and siMAD2-scramble/pcDNA3.1 (16% apoptotic and 3% necrotic) 
samples. In contrast, a small percentage of apoptotic cells (11% and 17%) detected in 
HCT116 MAD2-depleted cells and in siMAD2 scramble/ pcDNA3.1-p14 cells, 
respectively, was not statistically significant by the Student’s t-test (Fig. 14 B). The 
similarity between the percentage of apoptotic cells and the reduction of aneuploid cells 
after p14
ARF
 ectopic expression suggests apoptosis as a major mechanism to eliminate 
aneuploid cells (Fig. 14 B). Since the p14
ARF
 gene can act in p53-dependent and p53-
independent apoptotic pathways activated following DNA damage (Ozenne et al. 2010), I 
investigated whether p14
ARF
 cooperated with p53 activating apoptosis in response to 
aneuploidy. To this aim, I conducted a Western Blot analysis to evaluate the p53 protein 
levels. MAD2 post-transcriptional silencing and p14
ARF
 ectopic expression induced a 
significant increase of p53 protein levels compared to control. These findings suggest a 
possible collaboration between p14
ARF
 and p53 to counteract aneuploidy (Fig. 14 C). 
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Fig.14. p14
ARF 
ectopic expression induces apoptosis and increase of p53 protein levels in 
MAD2-depleted HCT116 cells. A: Examples of HCT116 cells stained with Orange Acridine and Ethidium 
Bromide 72 h after transfection; the orange arrow (merge panel, bottom left) points to live cells, yellow 
(white) and blue (gray) arrows points to necrotic and apoptotic cells (merge panel, bottom right), 
respectively. B: The graph summarizes the percentage of live, apoptotic and necrotic HCT116 cells 
transfected with pcDNA3.1 (1), pcDNA3.1-p14 (2), siMAD2 (3), siMAD2-scramble (4), 
siMAD2/pcDNA3.1 (5), siMAD2-scramble/pcDNA3.1-p14 (6), siMAD2/pcDNA3.1-p14 (7). The 
experiment was repeated at least twice. (Student’s t-test * P<0.05; ** P<0.01, n=150). C: Western blot 
analysis showing the increase of p53 protein levels after p14
ARF
 ectopic expression, in HCT116 pcDNA3.1-
p14 (2), HCT116 siMAD2 (3), and in HCT116 siMAD2/pcDNA3.1-p14 (4) cells when compared to HCT116 
control cells (1); on the right is showed the densitometric analysis of the WB to quantitate the p53 protein 
level that is normalized to -Tubulin. 
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To clarify the role of p53 in the induction of apoptosis after p14
ARF
 ectopic 
expression in aneuploid cells, I used HCT116 p53KO cells transfected with siMAD2 and 
pcDNA3.1-p14. The AO/EB assay in HCT116 p53KO cell, following p14
ARF
 ectopic 
expression showed that the percentage of apoptotic cells (20%) found in HCT116 
siMAD2/pcDNA3.1-p14 cells was comparable with the percentage found in cells 
transfected with siMAD2 and the pcDNA3.1 empty vector (18%). Following MAD2 post-
transcriptional silencing and p14
ARF 
ectopic expression, I detected a decrease of apoptotic 
cells in the absence of p53. This result suggests that cells were eliminated through a p53-
dependent apoptotic pathway where p14
ARF 
had a key role (Fig. 15 A). In agreement with 
this result cytogenetic analyses showed that siMAD2 induced higher number of aneuploid 
cells in HCT116 p53KO cells (61%) than siMAD2-scramble cells (21%). On the contrary, 
HCT116 p53KO cells that expressed p14
ARF
 ectopically showed a percentage of aneuploid 
cells (66%) similar to the percentage showed by HCT116 p53KO siMAD2/pcDNA3.1 
cells (77%) and HCT116-siMAD2 cells (61%). These differences were not statistical 
significant by the Student’s t-test. Thus, in the absence of p53, p14ARF did not induce the 
elimination of aneuploid cells caused by MAD2 depletion (Fig. 6B). Real Time qRT-PCR 
analyses confirmed that siMAD2#1 induced MAD2 gene post-transcriptional silencing of 
about 50% compared to siMAD2-scramble and p53KO HCT116 cells (Fig. 15 C).  
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Fig.15. p14
ARF
 does not induce apoptosis in HCT116 p53KO cells. A: On the left are showed 
representative pictures of the indicated cells stained with Orange Acridine and Ethidium Bromide 72 h after 
transfection; the graph on the right summarizes the percentages of live, apoptotic, and necrotic cells in 
pcDNA3.1 (1), pcDNA3.1-p14 (2), siMAD2 (3), siMAD2/pcDNA3.1 (4), and siMAD2/pcDNA3.1-p14 (5) -
HCT116 cells. B: The graph shows the percentages of aneuploid cells in p53 KO pcDNA3.1 (1), pcDNA3.1-
p14 (2), siMAD2-scramble (3), siMAD2 (4), siMAD2/pcDNA3.1 (5) and siMAD2/pcDNA3.1-p14 (6) 
HCT116 cells. All experiments were repeated at least twice. (Student’s t-test * P<0.05; ** P<0.01, n=150). 
C: Real time RT-PCR analysis showing RNA interference of siMAD2#1 and siMAD2 scramble in HCT116 
p53KO cells at 72 h after transfection. 
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3.2 CENP-E DEPLETION INDUCES ANEUPLOIDY THAT IS    
REDUCED BY THE TUMOR SUPPRESSOR p14
ARF
 
It was shown that mouse model can develop tumors when CIN is induced by 
haploinsufficiency of SAC genes but, on the other hand, sometimes the weakening of the 
SAC only is not enough and need additional mutations to induce carcinogenesis  (Giam & 
Rancati 2015).  To reconcile these observations we have to consider that only specific 
aneuploid karyotypes favor tumorigenesis. Alternatively, the observed differences in 
cancer susceptibility could be due to different levels of CIN in the various mouse models 
where some tissues accumulate different levels of CIN and are prone to transformation 
than other.  Another possibility stems from the observation that SAC genes have other non-
mitotic functions, as an example Mad2 can be involved in the DNA replication checkpoint 
in yeast (Sugimoto I. et al. 2004), and making it difficult to disentangle which function is 
associated to increased cancer susceptibility. Thus, I decided to look at CENP-E, a motor 
protein required for stable spindle microtubule capture at kinetochores (Yen et al. 1992; 
Schaar et al. 1997; Gudimchuk et al. 2013) which functions only in SAC signaling (Vitre 
et al. 2014) . 
It was reported that CENP-E homozygous knockout (CENPE
-/-
) mice experience 
massive chromosome segregation defects and embryonic lethality (Putkey et al. 2002). On 
the contrary, heterozygous knockout (CENPE
+/-
) mice are viable even though they exhibit 
elevated levels of aneuploidy and develop spleen and lung cancer (Weaver et al. 2007; Silk 
et al. 2013). However, it unknown if CENP-E heterozygosity could have effects on ploidy 
in not tumorigenic (normal) human cells similar to those observed in mice.  
Previously, I reported that p14
ARF
 counteract aneuploidy of HCT116 siMAD2 cells 
(Veneziano et al. 2016) and it was also reported that loss of the ARF tumor suppressor 
gene in mouse is sufficient to increase the number of near tetraploid cells (Britigan et al. 
2014). 
I decided then to induce CENP-E partial depletion in human primary fibroblasts 
IMR90 and in HCT116 cells lacking of p14
ARF 
expression and follow aneuploidy 
generation up to four weeks. In line, CENP-E depletion is an excellent strategy to induce 
aneuploidy and study the role of p14
ARF
 on the fate of these aneuploid cells.   
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3.2.1 CENP-E post-transcriptional silencing has no effect on cell proliferation 
To assess if CENP-E depletion induces aneuploidy I used the RNA interference 
strategy targeting transiently CENP-E  to generate primary human fibroblasts (IMR90) and 
near-diploid cells (HCT116) (Lengauer et al. 1997) with a CENP-E haploinsufficiency 
condition (~50% of gene expression).  
Initially I transfected the HCT116 cells with two different small interfering RNA 
(siRNAs) targeting the CENP-E transcript (siCENP-E #1, siCENP-E #2) and with 
unspecific siRNA targeting the green fluorescent protein (siGFP) as a control. Real-Time 
RT-PCR analysis showed decreased levels of CENP-E transcripts in transfected HCT116 
cells, demonstrating the efficacy of post-transcriptional silencing of both siRNAs. In 
comparison to WT cells, CENP-E transcriptional levels were reduced by ~50% and by 
~40% after transfection with siCENP-E #1 and siCENP-E #2, respectively. Because the 
goal is to obtain a haploinsufficiency condition I decided to conduct all subsequent 
experiments in HCT116 cells using the siCENP-E #1 (Fig.16 A). The same experiment 
was done in IMR90 cells and Real-Time RT-PCR analysis showed decreased levels of 
CENP-E transcripts when cells were transfected with siCENP-E #2 (~50%) and not with 
siCENP-E #1 (~97%). Accordingly, I decided to conduct all subsequent analysis in IMR90 
cells using siCENPE#2 (Fig.16 C). 
Early effects on cell proliferation of IMR90 and HCT116 siCENP-E cells were 
estimated by evaluating the cellular density/dish 24 48 and 72 hours post-transfection. In 
HCT116 cells I found a slowing down of proliferation at 48h after transfection of siCENP-
E. However, cells resumed normal growth levels at 72h in comparison to siGFP HCT116 
cells (Fig.16 B). This result suggests that the partial depletion of the checkpoint protein has 
no relevant negative effects on cell proliferation. When IMR90 cells were transfected with 
the siRNA targeting CENP-E we did not observe differences on cell proliferation at 24, 48 
and 72 hours after transfection: siCENP-E and siGFP IMR90cells show a similar growth 
profile (Fig.16 D). Consequently, weakening the mitotic checkpoint does not seem to 
affect the proliferation of both IMR90 and HCT116 cells.  
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Fig.16. CENP-E depletion does not affect cell proliferation in IMR90 and HCT116 cells. A: 
Real Time RT-PCR analysis showing RNA interference of siCENP-E #2 (4), siCENP-E #1 (3), siGFP (2) 
and WT (1) HCT116 cells at 72h after transfection. B: The graph shows HCT116 cell proliferation at 0, 48, 
and 72 hours after transfection of siRNA targeting CENP-E transcript (siCENP-E) and GFP transcript 
(siGFP) used as a control. C:  Real Time RT-PCR analysis showing RNA interference of siCENP-E #2 (4), 
siCENP-E #1 (3), siGFP (2) and WT (1) IMR90 cells at 72h after transfection. D: Cell proliferation graph of 
IMR90 cells after siCENP-E and siGFP silencing at 0, 48, and 72 hours. The experiment was repeated at 
least twice. (Student’s t-test: * P<0.05; ** P<0.01). 
   
3.2.2 CENP-E depletion induces different aneuploidy levels in HCT116 cells 
and IMR90 primary fibroblast  
In order to assess whether weakening the SAC by CENP-E post transcriptional 
silencing induces the same levels of aneuploidy in normal diploid cells (human primary 
fibroblasts IMR90) and in a near-diploid cell line that maintains a stable karyotype 
(HCT116) (Lengauer et al. 1997), I evaluated the presence of aneuploid cells with classical 
cytogenetics.  
Analysis of mitotic cells displayed significant levels of aneuploid cells (about 80%) 
72h after partial depletion (haploinsufficient condition) of CENP-E in HCT116 cells that 
do not express a p14
ARF
 functional protein (Burri et al. 2001). The majority of these mitotic 
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cells were hypodiploid (78%) and only a small part were hyperdiploid (5%) compared to 
control (Fig.17A). Since aneuploidy may be associated with aberrant mitosis, I evaluated 
the presence of mitotic spindle and chromosome alterations after CENP-E depletion in 
HCT116 cells. I detected many abnormal mitosis and, in particular, monopolar spindle 
(20%) and lagging chromosome (37%). These mitotic alterations could be the cause of the 
aneuploid cells development (Fig.17 B). This finding is in line with what was previously 
observed by others (Silk et al. 2013).  
At the same time, I made a post-transcriptional silencing of CENP-E in human 
primary fibroblasts IMR90 and analyzed the early effects on aneuploidy development. At 
72 hour after transfection I found about 50% of aneuploidy cells and, in particular, 30.5% 
of cells were  hypodiploid and 15% hyperdiploid compared to siGFP control cells (20% of 
hypodiploid and 3% of hyperdiploid) (Fig.17 C). Comparing aneuploidy levels of two 
different cell types I observed a dissimilar answer. In cells with a normal genetic 
background (IMR90) only half became aneuploid while in cells lacking p14
ARF
 protein 
(HCT116) the levels of aneuploidy were much higher (80%) (Fig. 17 D). These results 
suggest that the presence or not of p14
ARF
 may affect the development of aneuploidy.  
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Fig.17. Post transcriptional silencing of CENP-E induces aneuploidy. A: Representative pictures 
of aneuploidy and euploid metaphases found in siCENP-E and siGFP HCT116 cells after 72h of transfection; 
the graph shows  the percentages of aneuploidy (hypodiploid and hyperdiploid) cells in siGFP and siCENP-E 
HCT116 cells. B: Representative images of mitotic alterations (green: β-tubulin blue: DNA stained with 
DAPI); below, the graph shows the percentage of normal and altered metaphases (lagging chromosomes and 
monopolar spindle). C: Representative pictures of aneuploidy and euploid metaphases found in siCENP-E 
and siGFP IMR90 cells after 72h of transfection; below, the graph showing the percentages of aneuploid 
cells (hypodiploid and hyperdiploid) in siGFP and siCENP-E IMR90 cells. D: The graph summarizes and 
compares the percentage of siGFP (1) and siCENP-E (2) aneuploid cells found both IMR90 that HCT116 
cells. All experiments were repeated at least twice. (Student’s t-test * P<0.05; ** P<0.01, n=50 metaphases). 
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3.2.3 Aneuploid IMR90 cells return normal at long time after CENP-E 
depletion but not HCT116 cells.  
It has been reported that aneuploidy induced in response to a malfunction of the 
mitotic checkpoint is a condition that, sometimes, is not well tolerated by the cells. As a 
result, the cells selected to go forward in the proliferation are mainly diploid, while the 
aneuploid cells are subjected to negative selection (Siegel & Amon 2012; Weaver & 
Cleveland 2007; Giam & Rancati 2015). As aneuploidy has negative consequences for the 
fitness of normal cells, I wanted to evaluate proliferation up to four weeks of IMR90 and 
HCT116 cells CENP-E depleted. To this aim, cells were analyzed at different time (72 
hours, two weeks and four weeks) after transfection of CENP-E siRNA by cytogenetics. 
I found about 50% of aneuploidy cells in human primary fibroblasts 72 hours after 
CENP-E depletion and they are maintained up to two weeks. In detail, two weeks after 
siRNA transfection, I found 46% of aneuploidy cells (38% hypodiploid cells and 8% of 
hyperdiploid cells) compared to control IMR90 siGFP cells. However, aneuploidy cells 
dropped to 22.5% in IMR90 cells after four weeks by post-transcriptional silencing of 
CENP-E (20% hypodiploid and 2.5% hyperdiploid) similar to the percentage of found in 
control cells (20%). At two weeks, it seems that siCENP-E cells maintain aneuploidy, 
especially hypodiploid, while at four weeks it decreased to normal levels (Fig.18 A).  
 Regarding the proliferation of HCT116 aneuploid cells lacking of p14
ARF 
protein, I 
found about 80% of aneuploidy after 72 hours of CENP-E depletion and about 50% of 
aneuploidy after two weeks compared to control. After four weeks from CENP-E depletion 
HCT116 cells showed 35% of aneuploidy that is stably maintained compared to siGFP 
control. Though aneuploidy tends to decrease with time, sign that it has toxic effects on 
cells, a part of HCT116 cells keeps up a good level of aneuploidy for four weeks in 
absence of p14
ARF
 functional protein. These results suggest that cells with a normal genetic 
background tolerate aneuploidy only for a short period of time and then return to normal 
levels, while tumor cells lacking p14
ARF
 expression can tolerate aneuploidy  longer (Fig.18 
B). 
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Fig.18. Aneuploidy decreases in IMR90 cells but not in cells lacking of p14
ARF
 (HCT116). A: 
The graph shows the percentage of aneuploid and euploid siGFP (1) and siCENP-E (2) IMR90 cells at 72 
hours, 2 weeks and 4 weeks after siRNA transfection. B: Percentage of aneuploid and euploid siGFP (1) and 
siCENP-E (2) HCT116 cells (lacking of p14
ARF
 protein) displayed by the graph at 72 hours, 2 weeks and 4 
weeks after siRNA transfection.  All experiments were repeated at least twice. (Student’s t-test * P<0.05; ** 
P<0.01, n=50 metaphases).  
 
3.2.4 p14ARF counteract aneuploidy development. 
The different response to aneuploidy could be due to different p14
ARF
 protein levels 
between the two cell types used (HCT116 and IMR90 cells). To explore this hypothesis, I 
wanted to visualize the p14
ARF
 expression in IMR90 cells partially depleted for CENP-E at 
72 hours, 2 weeks and 4 weeks. The level of p14
ARF
 mRNA in IMR90 cells at 72 hours 
after the posttranscriptional silencing of CENP-E was similar to p14
ARF
 expression in the 
control (siGFP). However, p14
ARF
 expression was increased at two weeks and especially at 
four weeks from the CENP-E silencing. It should be noted that the increase of the p14
ARF
 
expression matches with the decrease of the aneuploid cells in IMR90 cells suggesting an 
involvement of the tumor suppressor in the control of cellular ploidy (Fig. 19 A).  
In line with this hypothesis, I estimated aneuploidy in HCT116 cells CENP-E 
depleted that were transiently transfected with the plasmid pcDNA3.1 coding for the 
p14
ARF
 c-DNA (Ayrault et al. 2006). This plasmid allows me to obtain transient expression 
of ectopic p14
ARF
, as I have done previously in HCT116 cells partially depleted for MAD2 
transcript.  
In pcDNA3.1-p14 HCT116 cells the aneuploidy level changed slightly in 
comparison to control (empty vector pcDNA3.1). As expected the number of aneuploid 
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cells dropped from 80% to 56% (46% hypodiploid and 10% hyperdiploid) after transient 
expression of p14
ARF
 in CENP-E depleted HCT116 cells. On the contrary, CENP-E 
depleted HCT116 cells and then transfected with the pcDNA3.1-empty vector still showed 
a high percentage of aneuploid cells (73%) similar to that shown by cells transfected with 
siCENP-E alone (Fig.19 B). This result is similar to the result obtained in HCT116 
siMAD2 cells but it allows me to reinforce the idea that p14
ARF
 re-expression counteracts 
proliferation of aneuploid cells caused by different stimuli. Consequently, I can generalize 
the role of p14
ARF
 gene to maintain stable the ploidy of the cells.  
 
 
 
 
Fig. 19. Involvement of p14
ARF
 in aneuploidy control. A: On the left, Real Time RT-PCR analysis 
showing p14
ARF
 mRNA expression levels in IMR90 siCENP-E cells at 72 hours, 2 weeks and 4 weeks after 
transfection compared to control. On the right, graph showing aneuploidy levels in siCENP-E IMR90 cells 
(2) from 72 hours up to 4 weeks compared to control siGFP IMR90 cells (1) (described in 4.2.3 paragraph). 
B: The graph displays the percentage of aneuploidy in pcDNA3.1 (1), pcDNA3.1-p14 (2), siCENP-E (3), 
siCENP-E/pcDNA3.1 (4), siCENP-E/pcDNA3.1-p14 (5) HCT116 cells.   
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3.3 ANEUPLOIDY IS NOT TOLERATE IN HCT116 CELLS 
EXPRESSING p14
ARF
 
Previous results suggest that cells lacking of the tumor suppressor p14
ARF
 respond 
differently to the induction of aneuploidy. It is conceivable that the genetic background 
plays a key role in the control of aneuploidy generation. For example, alteration of CENP-
E gene induces aneuploidy in MEFs and the simultaneous absence of ARF significantly 
increases its levels. In addition it was shown that MEFs ARF
-/-
 become aneuploid 
suggesting a role of the p14
ARF
 tumor suppressor in the control of aneuploidy (Silk et al. 
2013). In line with these results, I observed that in human cells depletion of SAC genes 
(MAD2 and CENP-E) induced aneuploidy that is increased in cells lacking of p14
ARF
 
expression (HCT116) compared to normal cells (IMR90) suggesting the idea that p14
ARF
 is 
involved to limit aneuploidy development.  
In order to evaluate if different p14
ARF
 expression levels may modulate the effect 
induced by CENP-E depletion in the cells, I engineered a tetracycline-regulated retroviral 
vector (pBPSTR1) for the inducible expression of p14
ARF
 that has been transfected in 
nearly diploid HCT116 tumor cells that does not have a functional p14
ARF
 (Burri et al. 
2001).  
 
3.3.1 Cloning of p14ARF c-DNA into pBPSTR1 vector 
In order to obtain the inducible expression of p14
ARF
 in the HCT116 cells, the 
coding sequence of p14
ARF
 was cloned in the pBPSTR1 retroviral vector (Fig. 20 A). The 
pBPSTR1 vector is a modified version of the pBABEpuro vector in which were cloned the 
two components of the inducible system “Tet-off”: tTA and TetO (Fig.20 C) (Pear et al. 
1993). The p14
ARF
 c-DNA was isolated from pcDNA3.1-p14 vector (kindly provided by 
Prof. S. Gazzeri, University J. Fourier, La Tronche, France) where it was cloned between 
the EcoRI e NotI restriction sites. To assure the correct extraction of the p14
ARF
 insert the 
restriction enzymes BamHI e XbaI cutting upstream and downstream of the insertion site 
were used (Fig. 20 B). Gel electrophoresis confirmed the extraction of the full length c-
DNA as revealed by the ≈ 500bp band (Fig. 20 B). The c-DNA was then purified from the 
agarose gel for the cloning in the pBPSTR1 vector. Cuts made by BamHI e XbaI are not 
compatible with the restriction sites present in the polylinker of pBPSTR1 and it was not 
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possible to clone the p14
ARF
 insert directly in the pBPSTR1 vector. To override this 
problem the p14
ARF
 insert was cloned blunt in the vector and the correct orientation was 
then checked. To make a blunt-blunt ligation of the p14
ARF
 c-DNA and the pBPSTR1 
plasmid, the 5'-protruding cohesive ends of the p14
ARF
 c-DNA, following BamHI/XbaI 
digestion, were treated with the Klenow fragment of  DNA polymerase I, that lacks of the 
5'-3' exonuclease activity, in a process called fill-in. The pBPSTR1 plasmid was digested 
with PmeI to generate the blunt ends, and gel electrophoresis confirmed the linearized 
pBPSTR1 vector (7022bp) by presence of the band of ≈7000bp (Fig. 20 C). The pBPSTR1 
vector was then, dephosphorylated with alkaline phosphatase to prevent its circularization 
in the next step of ligation. 
The ligation mix (ratio of 1:5 plasmid/insert) was used to transform E. coli 
competent cells. To verify the presence of the pBPSTR1-p14ARF construct the positive 
colonies were analyzed by the PCR colony assay with primers matching outside of the 
pBPSTR1 polylinker (Fig. 20 D). Two bacterial colonies containing the pBPSTR1-
p14ARF construct (Fig 20 D) were detected.  
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Fig.20. Engineering of the retroviral vector pBPSTR1 with the p14
ARF
 c-DNA. A: Experiment 
design scheme. B: Map of the vector pcDNA3.1 containing the p14
ARF
 cDNA. Boxed is the region where the 
cDNA was inserted; on the right, gel electrophoresis showing: not-digested pcDNA3.1-p14 (lane1) and 
BamHI/XbaI double-digested pcDNA3.1-p14 (lane2) identified with the marker λHindIII (lane M1) and 
marker 100bp ladder (lane M2). C: Map of the retroviral vector pBPSTR1. Boxed are the polylinker region 
and the site where the p14
ARF
 cDNA was inserted. On the right, gel electrophoresis showing: not-digested 
pBPSTR1 (lane1), PmeI digested pBPSTR1 (lane2) and marker λHindIII (lane M). D: Map of pBPSTR1 
vector with the primers mapping outside of the polylinker used for the PCR colony (highlighted in green). On 
the right gel electrophoresis of the amplicons of the PCR Colony assay showing: (lanes 1-3) positive colonies 
“1” and “3” as detected by the band at about 700bp; (lane 2) negative bacterial colony “2” detected by a band 
of 200bp; (lane 4) empty vector; (lane 5) no template; marker 100bp ladder (lane M). 
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Since the insert was cloned blunt to obtain the p14
ARF
 inducible expression, it is 
important to verify the appropriate 5'-3 'orientation of the insert cloned into the plasmid 
that must be with the 5’end downstream of the CMV promoter and the operator TetO (Fig. 
21). To this aim, I used three different methods to verify the correct orientation of the 
insert following blunt-blunt ligation. 1) PCR colony was set up with one primer designed 
on an insert sequence and the other one designed on the plasmid sequence adjacent to the 
polylinker site. The pairs of primers were chosen to obtain an amplification product only if 
the insert was cloned in the correct orientation (Fig.21 A).  The gel electrophoresis showed 
that the bacterial colonies 1 and 3 contained the pBPSTR1 vector with the correct 
orientation of the p14
ARF
 insert (Fig.21 A). 2) The plasmid DNA extracted by the colonies 
1 and 3 was digested with EcoRI that has a single cutting site in the vector pBPSTR1 and a 
second site in the sequence of the insert, in order to discriminate the correct orientation 
according to the length of the fragments obtained.  (Fig.21 B). 3) The plasmid DNA of the 
colony 1 was sequenced (BMR Genomics, Padua, Italy). The primers used for the reaction 
mapped upstream and downstream of the cloning site and were previously used in the PCR 
colony reactions. The DNA sequencing confirmed the presence of the insert in the correct 
orientation (Fig. 21 C).  
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Fig.21. Colony screening to verify the correct orientation of the insert. A. Top: map of 
pBPSTR1 where the p14
ARF
 c-DNA was cloned (red arrow indicates the 5’-3’ insert orientation) and position 
of the primers used for the Colony PCR assay. Bottom: agarose gel electrophoresis of colonies 1 and 3 PCR 
products of pBPSTR1-p14ARF (M=marker 100bp ladder) using primers 1 and 3 (green & yellow arrows) 
(lanes 1-2), primers 4 and 2 (lanes 3-4), primers 1 and 4 (lanes 5-6) and with no template (lane 7). B. Top: 
map of pBPSTR1-p14ARF where the red arrow indicates the 5’-3’ insert orientation and the black rectangles 
indicate the EcoRI sites. Bottom: agarose gel electrophoresis of colony 1(lanes 1-2-3) and colony 3 (lanes 4-
5-6) after EcoRI digestion; pBPSTR1-p14ARF vector uncut (lane 1-4), pBPSTR1-p14ARF linearized with 
BamH1 (lane 2-5), pBPSTR1-p14ARF cut with EcoRI (lane 3-6) and marker λHindIII (lane M). C: 
Sequencing (both directions) with vector specific primers confirmed the presence of the cloned p14
ARF
 cDNA 
in the pBPSTR1 expression vector.       
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3.3.2 Generation of pBPSTR1-p14ARF HCT116 cells 
The retroviruses containing the pBPSTR1-p14ARF construct were produced in the 
Phoenix Amphotropic packaging cell line (Pear et al. 1993). The Phoenix cells were 
previously cultured for a week in medium containing Hygromycin-B (300μg/ml), because 
gag and pol viral genes are inserted in the cells along with the gene for Hygromycin-B 
resistance, and then they were transfected with pBPSTR1-p14ARF vector. After 72 hours 
of transfection, the medium was collected, filtered, and Polybrene (a cationic polymer) was 
added to increase the efficiency of infection in HCT116 cells. Then HCT116 cell was 
selected using Puromycin (2µg/mL) for at least ten days. Preliminary, to assess the Tet-Off 
functionality it was done an experiment by transfecting the pBPSTR1-H2BGFP vector 
expressing the H2BGFP protein (the H2B histone fused with the Green Fluorescent 
Protein) in HCT116 cells. The analysis of these transfected cells by fluorescence 
microscopy indicated that the treatment with Doxycycline (2µg/mL) for 96 hours was 
sufficient to reduce the expression of the H2BGFP fusion protein (Fig. 22 A).  
To evaluate both the presence of the ectopic p14
ARF
 and the amount of its transcript 
level, it was done a PCR reaction with specific primers mapping in the pBPSTR1-p14ARF 
sequence (showed in Fig.21A) in stably transfected HCT116 cells. Agarose gel 
electrophoresis confirmed the presence of the p14
ARF 
insert in pBPSTR1-p14 HCT116 
cells after its amplification from genomic DNA (Fig.22 B). The Real Time RT-PCR assay 
showed the presence of highest levels of p14
ARF
 in pBPSTR1-p14ARF HCT116 cells 
compared to wild type HCT116 and to HCT116 cells harboring the pBPSTR1-H2BGFP 
plasmid (Fig. 22 C).  
To exclude any side effects of the presence of ectopic p14
ARF
 it was necessary to 
evaluate that its re-expression did not alter normal cellular proliferation in HCT116 cells. 
The effects on cell proliferations of the re-expression of p14
ARF
 were estimated by 
evaluating the cellular density/dish for 96 hours in pBPSTR1-p14ARF HCT116 cells. Not 
significant differences between the proliferation rate of HCT116 cells expressing p14
ARF
 
and H2BGFP or WT control cells were observed (Fig. 22 D). This result indicates that the 
re-expression of p14
ARF
 gene in HCT116 cells does not affect cell proliferation.  
In addition the pBPSTR1-p14ARF HCT116 cells showed level of aneuploid cells 
similar to that found in pBPSTR1-H2BGFP or WT-HCT116 cells suggesting that re-
expression of p14
ARF
 has not effects on cellular ploidy (Fig. 22 E).  
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Fig.22. Engineering of HCT116 cells with the retroviral construct pBPSTR1-p14
ARF
 and initial 
characterization. A: Evaluation of the functionality of the Tet-Off System by treating the stably infected 
H2BGFP-HCT116 cells with Doxycycline for 96 hours showed a remarkable decline in the number of 
H2BGFP positive cells. B: Correct integration of the retroviral vector in genomic DNA as revealed by PCR 
using specific primers mapping in the vector. C: Real time RT-PCR showing overexpression of p14
ARF
 in 
stably infected HCT116 cells compared to controls. (Student’s t-test * P<0.05; ** P<0.01, n=4) D: 
Proliferation assay showed normal cell proliferation in HCT116 cells that re-express p14
ARF
 tumor 
suppressor gene compared to H2BGFP and WT HCT116 control cells. E: Cytogenetic analysis showed no 
ploidy changes between pBPSTR1-p14ARF and control cells. 
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3.3.3  p14ARF counteract aneuploidy induced by CENP-E posttranscriptional 
silencing  
Once confirmed that p14
ARF
 re-expression does not affect the normal proliferation 
and the ploidy of HCT116 cells, I used these engineered cells to corroborate the hypothesis 
that p14
ARF
 gene has an important role in limiting the proliferation of aneuploidy cells. To 
this aim, CENP-E was posttranscriptional silenced to induce aneuploidy in pBPSTR1-
p14ARF HCT116 cells. The percentage of induced aneuploid cells was then estimated by 
modulating p14
ARF
 expression levels by using Doxycycline, analogue of Tetracycline, 
which prevents the binding of the trans-activator (tTA) to the promoter.  
First of all, I checked the siRNA targeting CENP-E transcript (siCENP-E), 
previously used for the WT HCT116 cells, was able to induce CENP-E haploinsufficiency 
in pBPSTR1-p14ARF HCT116 cells. The qRT-PCR confirmed that the RNA interference 
strategy reduced of about 40% the transcription levels of CENP-E (Fig. 23 A).  
As said (4.1.1 paragraph), the p14
ARF
 ectopic expression reduced the proliferation 
of MAD2 silenced HCT116 cells so I wanted to assess whether the presence of the tumor 
suppressor induced a reduced proliferation even in pBPSTR1-p14ARF HCT116 cells 
CENP-E depleted.  To this aim, I estimated the cellular proliferation by evaluating the 
cellular density/dish 24, 48 and 72 hours after CENP-E transfection. Likewise, I found a 
significant reduction of cell proliferations at 48 and 72 hours after CENP-E silencing in 
HCT116 cells engineered for p14
ARF
 expression compared to control (Fig.23 B).  
Previously, I observed that p14
ARF
 could reduce aneuploidy levels of 25-30% both 
in siMAD2 and in siCENP-E HCT116 cells (paragraph: 4.1.2 and 4.2.4). To explore if the 
stable p14
ARF
 expression had the same effects in pBPSTR1-p14ARF HCT116 cells, I 
conducted a cytogenetic analysis to evaluate the ploidy after CENP-E depletion. The re-
expression of p14
ARF
 greatly reduced the percentage of aneuploid cells (Fig. 23 C).  
Since the pBPSTR1-p14ARF inducible vector allows modulation of p14
ARF
 
expression I evaluated the number of aneuploid cells induced by CENP-E depletion after 
treating the pBPSTR1-p14ARF HCT116 cells with doxycycline that decreases p14
ARF
 
level.  
As shown in the Figure 23D, the stable expression of p14
ARF
 in HCT116 cells has 
reduced the number of aneuploid cells induced by CENP-E depletion (≈22%) in 
comparison to that showed by the siCENP-E HCT116 cells (≈80%) and similarly with the 
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percentage of siGFP HCT116 cells (≈10%). On the contrary, the pBPSTR1-p14ARF cells 
silenced for CENP-E showed more aneuploid cells (≈45%) following treatment with 
doxycycline, which no had effect on pbpSTR1-p14ARF HCT116 cells transfected with the 
siGFP control (≈10% of aneuploid cells) (Fig.23D). 
These results suggest that cells with reduced expression of p14
ARF
 cannot properly 
counteract aneuploidy confirming and extending the crucial role played by p14
ARF
 in the 
maintenance of genomic stability. 
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Fig.23. Aneuploidy induced by CENPE depletion is limited in HCT116 cells stably expressing 
p14
ARF
. A: Real time RT-PCR showing reduction of CENP-E transcript in HCT116 cells stably expressing 
p14
ARF
. B: The graph shows cell proliferation of pBPSTR1-p14ARF HCT116 cells silenced for CENP-E at 0, 
48, and 72 hours post transfection in comparison to the control. C: The graph shows that aneuploid cells 
induced by MAD2 or CENP-E depletion are greatly reduced by p14
ARF
 ectopic expression as well in 
HCT116 cells CENP-E depleted and stably expressing p14
ARF
. D: pBPSTR1-p14ARF HCT116 cells depleted 
for CENP-E and treated with Doxycycline (2µg/mL) that decreases p14
ARF
 show more aneuploid cells 
compared to siCENP-E untreated cells. The experiment was repeated twice (Student’s t-test * P<0.05; ** 
P<0.01, n=50).    
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CHAPTER 4: DISCUSSION 
Cells with altered chromosome numbers are frequently found in cancerous tissues, 
miscarriage embryos as well as in disabled born children such as trisomy 21 patients 
(Holland & Cleveland 2012). Many studies on aneuploid tissues and embryos documented 
that changes in chromosome number lead to growth retardation and in most cases to 
embryonic lethality (Siegel & Amon 2012). In contrast, many cancerous tissues display 
high levels of cells with altered chromosome number suggesting that these cells could 
benefit from altered protein expression levels due to changes in chromosome number and 
outcompete cells with normal diploid chromosome content (Pellman 2007). Genetic 
analyses have hypothesized that for malignant transformation are needed at least six gene 
mutations (Vogelstein 1996) but it is rare for a single cell to acquire all necessary 
mutations considering the mutation rate in humans. Thus, it was born the idea that 
destabilizing the genome is necessary for cancer development and the chromosomal 
instability (CIN), which results in gains or losses of whole chromosomes or translocation 
of chromosome segments, can be a strategy to accumulate the mutant alleles essential for 
malignant proliferation (Gordon et al. 2012). Although the phenotypes of cells and tissues 
with altered chromosome numbers were often described, underlying mechanisms that lead 
to the aneuploidy phenotype remain unknown. Consequently, it is difficult identify key 
pathways that could prevent aneuploidy development.  
Cancer cells can have gross abnormalities in their chromosome numbers, most as a 
result of defects in the quality control of sister chromatid separation (Weaver et al. 2007). 
During mitosis the proper chromosomes segregation is controlled by a specific checkpoint, 
the Spindle Assembly Checkpoint (SAC). If any of SAC components is mutated or its 
expression is reduced, miss-segregation events would not be correctly reported, promoting 
aneuploidy development (Silva et al. 2011). In most cases, aneuploidy cells are often 
eliminated by protecting mechanisms. Enhanced proteasomal degradation has been 
suggested as one aneuploidy tolerating mechanisms (Torres et al. 2010). Also, the p38-p53 
axis has been suggested as a pathway limiting the proliferation of aneuploid cells 
(Thompson & Compton 2010). It was also suggested that heightened energy metabolism in 
aneuploidy cells may be behind the surge in ROS levels. Increased ROS cause DNA 
damage that activates the ATM/P53 pathway, and this depends on the severity of 
aneuploidy (Li et al. 2010). Aneuploidy could potentially increase the risk of neoplastic 
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transformation but it seems that this process occur when it is associated with mutations in 
tumor suppressor genes.  
In this thesis, I propose an alternative protective mechanism carried out by the 
tumor suppressor p14
ARF
 against aneuploidy development. The p14
ARF
 protein plays 
several biological functions in the cell with the purpose to suppress aberrant cell growth. 
The well-defined function of p14
ARF
 is to stabilize and activate p53 by neutralizing the 
inhibitory effects of the E3 ubiquitin ligase hMdm2 in response to oncogenic stress 
(hyperproliferative signals) (Sharpless 2005). Though the p14
ARF
 protein is a key player in 
this p53 pathway, there are evidences that it could promote a p53-independent cell cycle 
arrest and/or apoptosis (Weber et al. 2000; Müer et al. 2012). p14
ARF
 expression is 
generally lost by deletion or hypermethylation of CpG islands localized at its promoter 
region (Badal et al. 2008). Hypermethylation of p14
ARF
 promoter has been reported in 
many tumors, and this loss occurs at early stages of tumorigenesis in some tumors such as 
colorectal, gastric, prostate, and breast cancer (Ozenne et al. 2010). In many human 
cancers, deregulation of the p53 pathway usually occurs by inactivation of the TP53 gene 
through point mutations. Moreover, inactivation of the p14
ARF
 gene has been proposed as a 
mechanism that disrupts p53 activity in tumors with wild-type TP53 gene (Nyiraneza et al. 
2012).  
In agreement with other data (Amato et al. 2009), I showed that weakening the 
SAC by MAD2 post-transcriptional silencing increased aneuploidy in HCT116 cells 
(lacking of p14
ARF
). However, when the p14
ARF
 functionality was restored by ectopic 
expression of p14
ARF
, aneuploidy and the proliferation rate was reduced in these aneuploid 
cells (4.1.1 and 4.1.2 paragraphs). At the same time, mitotic abnormalities observed after 
MAD2 post-transcriptional silencing decreased as a result of p14
ARF
 ectopic expression. 
These preliminary findings suggest that p14
ARF
 is able to prevent proliferation of aneuploid 
cells caused by reduction of SAC activity (paragraph: 4.1.2).  
In line with other results where human primary fibroblast activated a premature 
cellular senescence response p53-mediated after induction of aneuploidy by MAD2 post-
transcriptional silencing to halt aneuploidy cells proliferation (Lentini et al. 2012), I 
wanted to investigate if p14
ARF
 triggered this pathway even in MAD2 depleted HCT116 
cells. By contrast, I found that premature cellular senescence was not activated in response 
to aneuploidy in HCT116 tumor cells where p14
ARF
 was ectopically expressed. Instead, the 
presence of apoptotic cells in MAD2-depleted HCT116 tumor cells, in response to p14
ARF
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ectopic expression, suggested induction of apoptosis as the mechanism adopted by p14
ARF
 
to counteract aneuploid cells proliferation. At this point, I wanted to investigate on possible 
partners of p14
ARF
 that collaborate to activate apoptosis in response to aneuploidy. 
Apoptosis was associated with the increase of p53 protein, suggesting that the transient re-
expression of p14
ARF
 in these aneuploid cells induces a p53-dependent apoptosis. The 
existence of a p14
ARF
-p53 axis is confirmed by experiments done in HCT116 p53KO cells, 
where cells interfered for MAD2 become aneuploid but did not show increased number of 
aoptotic cells when p14
ARF
 was re-expressed (paragraph: 4.1.3).  
Previously, it has been shown that aneuploidy caused by MAD2 haploinsufficiency 
increased both the frequency and the number of tumors in a p53
-/-
 background (Holland & 
Cleveland 2009). Consistent with this hypothesis, it was reported that a p38 kinase-
dependent stress response activates p53 to induce the p21
waf1
 in response to chromosome 
missegregation in HCT116 cells (Thompson & Compton 2010). Likely, the cellular signal 
triggering this pathway relies on the presence of DNA damage that could be caused by 
chromosomal mechanical stress (Janssen et al. 2011). On the contrary, the results of this 
thesis suggest that, after p14
ARF
 re-expression, apoptosis activation p53-dependent hampers 
aneuploid cell proliferation.  
It has been documented that MAD2 as well as others SAC genes have no-mitotic 
functions making it difficult to identify which specific alteration could activate the p14
ARF
 
response (Giam & Rancati 2015). For example, it was seen that MAD2 may be involved in 
the DNA replication checkpoint in yeast (Sugimoto et al. 2004). Thus, it becomes 
important to verify that the p14
ARF
 response is indeed linked only to the aneuploid 
stimulus. I choose then to induce aneuploidy using the post-transcriptional silencing of 
CENP-E gene which is required only in mitosis for stable spindle microtubule capture at 
kinetochores (Yen et al. 1992; Schaar et al. 1997; Gudimchuk et al. 2013) and evaluate the 
effects both in  near diploid cells lacking of p14
ARF
 HCT116 cells that in human primary 
fibroblasts. Until now, it is known that the reduction of CENP-E induces aneuploidy in 
MEFs that potentially could promote tumorigenesis in mouse (Weaver et al. 2007; Silk et 
al. 2013). Accordingly, I found that CENP-E depletion caused aneuploidy both in human 
primary fibroblasts IMR90 and in HCT116 cells. However, the number of aneuploid cells 
was higher in HCT116 cells than in IMR90 cells and could be explained by the lack of 
p14
ARF
 functionality in the HCT116 cells (paragraph: 4.2.2). These results are consistent 
with MEFs CENPE
+/-
/ARF
-/-
 showing high rate of aneuploidy unlike MEFs CENPE
+/-
/ARF
+/+
 (Weaver et al. 2007; Silk et al. 2013).  
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CENP-E depletion has not relevant influence on cell proliferation of both kind of 
cells (paragraph4.2.1) but induced mitotic abnormalities like monopolar spindle and 
lagging chromosomes that could explain the aneuploidy generation as seen in mouse (Silk 
et al. 2013). It was reported that aneuploidy cells are promptly outcompeted by normal 
cells in culture (Thompson & Compton 2010) and do not exist data about the fate of 
induced aneuploid cells at longer time from induction than 72 hours. Also in this case, the 
two different cell types have responded differently. At four weeks after CENP-E depletion 
aneuploidy returned at normal levels in human primary fibroblasts IMR90 cells while 
HCT116 cells showed still aneuploid cells although the percentage of aneuploidy 
decreased when compared to that at 72 hours. The finding that aneuploid cells were found 
up to two weeks in IMR90 cells suggests that a threshold level of p14
ARF
 protein must be 
reached to activate a pathway that block aneuploidy cells proliferation (Groth et al. 2000). 
Also, it is interesting to notice that IMR90 cells were still aneuploid at two weeks after 
CENP-E depletion but with a different profile showing a marked decrease of hyperdiploid 
cells (paragraph: 4.2.3). Probably, the tumor suppressor p14
ARF
 is able to counteract 
hyperdiploidy in agreement with other data showing that loss of ARF is sufficient to 
increase the number of near tetraploid cells in the mouse (Britigan et al. 2014). 
The increased p14
ARF
 expression levels at 72 hours, 2weeks and 4weeks after 
CENP-E silencing and the simultaneous aneuploidy decrease in IMR90 cells suggested the 
involvement of the tumor suppressor to limited aneuploidy proliferation. Similarly, the 
p14
ARF
 ectopic expression in CENP-E depleted HCT116 cells induced a decrease of the 
percentage of aneuploid cells (paragraph: 4.2.4). 
Interestingly, aneuploidy induced by CENP-E depletion was not tolerated in 
pBPSTR1-p14ARF HCT116 cells. This finding strongly suggests that the re-expression of 
p14
ARF
 blocked aneuploidy development. The level of aneuploidy in these cells resulted 
lower than cell expressing transiently p14
ARF 
both in siMAD2 and in siCENP-E HCT116 
cells (paragraph: 4.3.3). Moreover, the post-transcriptional silencing of CENP-E in 
HCT116 cells stably expressing p14
ARF
 negatively influenced the cellular proliferation 
confirming that the tumor suppressor limited aneuploidy. The reduction of p14
ARF
 trough 
Doxycycline treatment increased aneuploid cell numbers suggesting that aneuploidy 
development is influenced by p14
ARF
 expression levels (paragraph: 4.3.3).  
Generally, gene expression correlates with gene copy number. Aneuploidy 
unbalancing genomic material could then induce a signal resembling hyperproliferative 
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stress typically sensed by p14
ARF
. Likely, p14
ARF
 could signal the presence of gene 
expression imbalance resulting from chromosome missegregation and activate apoptosis 
p53-dependent, as previously described (Williams et al. 2008). 
Taken together, these results reinforce the idea that the abolition of p14
ARF
 
expression or p14
ARF
 related partners that control genomic stability is one of the strategies 
adopted by human tumor cells to tolerate aneuploidy.      
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CHAPTER 5: MATERIALS AND METHODS 
5.1 Cells and cell culture 
Human primary fibroblasts (IMR90, ATCC) were cultured in EMEM supplemented 
with: 10% FBS (GIBCO, Invitrogen, Monza Italy), 100units/ml penicillin and 0, 1 mg/ml 
streptomycin, 1% NEAA; Colon cancer cells HCT116 with MIN phenotype (near-diploid 
cells) and p53
-/-
 HCT116 cells (kindly provided by Dr. B. Vogelstein, John Hopkins 
University, Baltimore, MD) were cultured in D-MEM with 10% FBS (GIBCO, Invitrogen, 
Monza, Italy), 100 U/ml penicillin and 0.1 mg/ml streptomycin. Cells were cultured in a 
humidified atmosphere of 4% CO2 in air at 37° C. 
5.2 Cells Transfection  
For siRNAs transfection 1,5x10
5
 IMR90 cells and 2,5x10
5
 HCT116 cells were 
plated in 6-well dishes and incubated at 37°C. Specific siRNAs duplex were mixed with 
Lipofectamine2000 Reagent (Invitrogen), according to manufacturer’s recommendation 
and added to the cells. After 6 hours at 37°C, the transfection medium was replaced with 
fresh medium. Twenty-four hours after plating, HCT116 cells were transfected with 
siRNAs targeting MAD2 siRNA n°1 (5’-AUACGGACUCACCUUUTT-3’), MAD2 
siRNA n°2 (5’ –AAGUGGUGAGGUCCUGGAATT– 3’) or with control MAD2 scramble 
siRNA (5’- CAGUCGCGUUUGCGACUGG- 3’), siRNA GFP 
(5’GGCUACGUCCAGGAGCGCACC-3’), CENP-E siRNA n°1 (5’-
AAGCAGAGAGAAGGGUGAACC-3’) at a final concentration of 60 nM. After 
additionally five hours these cells were transfected with the pcDNA3.1 empty plasmid or 
harbouring the p14
ARF
 c-DNA (kindly provided by S. Gazzeri, University J. Fourier, La 
Tronche, France). IMR90 cells were transfected with control siRNA GFP and CENP-E 
siRNA n°2 (5’–AACGAAGAGUUACUUGGUGCC–3’) at a final concentration of 40nM. 
The day of transfection the siRNA or the plasmid DNA and the transfection reagent 
(Lipofectamine 2000, Invitrogen, Monza, Italy) were diluted separately in Opti-MEM 
(Invitrogen, Monza, Italy) mixed gently and then incubated for 5 min at room temperature. 
After incubation the siRNA and the plasmid DNA were mixed gently with Lipofectamine 
2000 (Invitrogen, Monza, Italy), allowed to sit 20 min at room temperature to allow 
complex formation, and added to the plates with 2ml of Medium for 72 h. 
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5.3 Stable expression of p14ARF in HCT116 cells 
To generate HCT116 cells expressing p14
ARF
 protein, the c-DNA of p14
ARF
 from 
pcDNA3.1 was cloned in inducible retroviral vector pBPSTR1. Then using Phoenix 
packaging cells, the recombinant retroviral was used to infect HCT116 cells. Using the 
TET-off system, the expression of p14
ARF
 was modulated by doxycycline at the 
concentration of 2µg/mL.  
 
5.3.1 Purification of p14ARF c-DNA from pcDNA3.1 and “Fill in” 
protocol 
An aliquot of pcDNA3.-p14 plasmid was subjected to double digestion using the 
restriction enzymes BamHI and XbaI to isolate the c-DNA. The reaction mixture (Vf 
=100µL) contained: 
 20μg pcDNA3.1-p14 
 5μl BamHI (10u/μl) 
 5μl XbaI (10u/μl) 
 10μl Buffer Tango 10x  
 60μl H2O DNAsi/RNAsi free 
The mixture was incubated at 37°C for 2 hours.  
Electrophoresis on 1% agarose gel, with ethidium bromide (0,5μg / ml) in TAE 
buffer (40mM Tris-acetate, 1mM EDTA), was used to purify the correspondent band of 
p14
ARF
 c-DNA (≈ 500bp) with PureLink Quick Gel Extraction Kit extraction PCR 
Purification COMBO kit (Invitrogen). Then the p14
ARF
 cDNA was subjected to “Fill in” 
reaction: 
 20μg DNA 
 3μl Buffer NEB2 
 3μl dNTP 1mM (Cf = 0,1mM) 
 1,5μl BSA (1μg/μl) 
 0,5μl frammento di Klenow (Roche)  
The mixture was incubated at 37°C for 30 minutes.  
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5.3.2 Digestion, de-phosphorylation and purification of pBPSTR1 
An aliquot of pBPSTR1 retroviral vector was subjected to digestion using the 
restriction enzymes PmeI to obtain blunt end for 2 hours at 37°C. The reaction mixture was 
performed with:  
 3,5μg DNA 
 1μl PmeI 
 2μl Buffer B  
 13,5μl H2O 
 Then the vector was precipitate with NaAc 0,3M ed EtOH, suspended in 20 µl of 
TE buffer and dephosphorylated with alkaline phosphatases of calf intestine (CIAP). The 
mixture was incubated at 50°C for 10 minutes and then at 68°C for 10 minutes. The vector 
was purified with phenol-chloroform protocol and precipitated with NaAC 0.3M and 
absolute EtOH.  
 
5.3.3 Quantification of p14ARF c-DNA and pBPSTR1 vector 
pBPSTR1 plasmid and p14
ARF
 c-DNA was subjected to  electrophoresis on 1% 
agarose gel, with ethidium bromide (0,5μg / ml) in TAE buffer (40mM Tris-acetate, 1mM 
EDTA), and quantized using 2-Log DNA Ladder 100ng/μl (New England Biolabs). 
 
5.3.4  Ligation reaction between p14ARF c-DNA and pBPSTR1 vector 
The ligation mix was performed in 20µl using a molar ratio of 1:5 vector to insert:  
 0,5µl pBPSTR1 
 6µl of c-DNA BamHI filled / XbaI filled 
 2µl di Buffer 
 0,5µl di Ligase 
 11µl H2O 
Reaction incubated at 12°C o.n.  
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5.3.5 Transformation of E. Coli with pBPSTR1-p14ARF construct   
The ligase mixture was used for transformation of competent cells of E. coli 
(XL1Blue strain) using thermal shock protocol. The suspension was seeded in a Petri dish 
containing agar supplemented with ampicillin 100μg / ml and incubated overnight at 37 ° 
C in order to select the transformed bacteria. From the transformation several colonies 
were obtained, subsequently subjected to a colony PCR reaction with primers specific for 
the vector sequences and the insert. 
For the colony PCR, part of the colony was picked from the plate and dissolved in 
sterile H2O in a PCR tube. After the first step at 95 ° C for 3 minutes, to take place lysis of 
bacterial cells, it was added 20µl of reaction mixture: 
 12,5µl REDTaq ReadyMix PCR Reaction Mix con MgCl2 (Sigma Aldrich 
Inc.) 
 1,25µl primer Fw 4µM 
 1,25µl primer Rv 4µM 
 5µl H2O 
Thermic profile:  
 
 
 
 
 
 
 
 
Oligo Sequence 5’-3’ 
pBPSTR1-Fw CCAGACGACGAGGCTTGC 
pBPSTR1-Rev GACGCCATCCACGCTGTTTTG 
P14-Fw GGTTTTCGTGGTTCACATCCCGC 
P14-Rev CAGGAAGCCCTCCCGGGCAGC 
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5.3.6 Phoenix cells: protocols 
Twenty four hours before transfection of retroviral vector, PHOENIX cells were 
seeded in 100mm Petri dish in number 3.000.000, in order to have at the time of 
transfection a confluence of 70%, optimally to ensure high transfection efficiency. The day 
of transfection, the plasmid DNA and the transfection reagent (Lipofectamine 2000, 
Invitrogen, Monza, Italy) were diluted separately in Opti-MEM (Invitrogen, Monza, Italy) 
mixed gently and then incubated for 5 min at room temperature. After incubation the 
plasmid DNA were mixed gently with Lipofectamine 2000 (Invitrogen, Monza, Italy), 
allowed to sit 20 min at room temperature to allow complex formation, and added to the 
plates with 8ml of Medium. After 72 hours, the medium with the viral particles produced 
was collected from the Petri dish and filtered through a syringe filter with 0,45μm; 4ml of 
solution, supplemented with Polybrene 4μg/ml, were used for the infection of HCT116 
cells, seeded the day before in a plate from 100mm to 3.000.000. In the plate it was added 
1 ml of DMEM to obtain a total volume of 5ml. After 5 hours 3ml of DMEM was added at 
the plate to obtain volume of 8ml. 
After 24 hours post infection, the culture medium was removed and fresh medium 
was added (8 ml).  
 
5.3.7 Inducible expression of p14ARF in HCT116 cells 
After 72h post infection of pBPSTR1-p14 retroviral vector of HCT116 was added 
Puromycin (1μg/ml) in the culture medium, for the selection of stably infected HCT116 
cells. The selection was carried out for a week.  
To modulate the p14
ARF
 expression we used doxycycline at the final concentration 
of 2µg/mL to obtain the reduction of p14
ARF
 (TET OFF system).   
 
5.4 Cell viability 
To assess cell viability cells were transfected with the specific siRNA (siMAD2, 
siMAD2 scramble, siGFP, siCENPE)  and the plasmids pcDNA3.1 (empty) and 
pcDNA3.1-p14 for 72 h, harvested by trypsinization and collected in a tube with 4ml of 
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phosphate buffered saline (PBS). Cell suspensions (100 ml) were mixed with 100 ml of 
Trypan Blue (Sigma–Aldrich, Milan, Italy) and 10ml were placed in a Burker chamber for 
cell counting. 
5.5 Real time qRT-PCR 
Primers to be used in Real-Time qRT-PCR experiments were designed with Primer 
Express software (Applied Biosystems, Monza, Italy) choosing amplicons of 70–100 bp. 
The selected sequences were tested against public databases (BLAST) to confirm the 
identity of the genes. Total RNA was extracted from cells by using the RNAeasy Mini kit 
according to the manufacturer’s instruction (Qiagen, Milan, Italy). RNA was reverse-
transcribed in a final volume of 40ml using the High Capacity c-DNA Archive kit (Applied 
Biosystems) for 10 min at 25°C and 2 h at 37°C. Real-Time qRT-PCR reaction was 
performed as previously described (Barra et al. 2012). Real-Time qRT-PCR was done in a 
final volume of 20ml comprising 1X Master Mix SYBR Green (Applied Biosystems) and 
0.3mM of forward and reverse primers for MAD2 (Fwd: 50-
GCCGAGTTTTTCTCATTTGG-30; Rev 50-CCGATTCTTCCCACTTTTCA-30), CENP-
E (Fwd: 5’-GTGGGACCAGTTCAGCCTGATA-3’; Rev: 5’-
CCAAGTGATTCTCTCTGCTGTTC-3’), GAPDH (Fwd:5’-
CTCATGACCACAGTCCATGCC-3’; Rev:5’-CAATCCACAGTCTTCTGGGT-3’), 
p14
ARF
 (Fwd:5’- CGAGAACATGGTGCGCAGGT-3’; Rev: 5’-
GATGTGAACCACGAAAACCCTC-3’). 
5.6 Western Blotting 
Protein concentration was measured using the Bio-RadProtein Assay (Bio-Rad, 
Milan, Italy). Proteins (50mg) were separated by 10% SDS-PAGE containing 0.1% SDS 
and transferred to Hybond-C nitrocellulose membranes (Amersham Life Science, 
LittleChalfont, England) by electroblotting. The membranes were sequentially incubated 
with primary antibodies against p53 (mouse, ab1101 Abcam, Cambridge, UK), MAD2 
(goat, C19-Santa Cruz, Heidelberg, Germany), p14
ARF
 (goat, C18-Santa Cruz, Heidelberg, 
Germany) and HRP-conjugated mouse (ab6789, Abcam, Cambridge, UK), or goat 
(ab97110, Abcam, Cambridge, UK) as secondary antibodies. The target protein was 
detected with enhanced chemiluminescence Western blotting detection reagents (Pierce, 
Milan, Italy). Membranes were stained by Ponceau-Red to confirm equivalent loading of 
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total protein in all lanes. We used antibody against b-tubulin (mouse, SIGMA,Milan, Italy, 
1:10,000) to confirm proteins loading. The WB bands were quantified with “Image Lab” 
software (Bio-Rad, Milan, Italy). 
5.7 Determination of ploidy 
Cells were treated with 0.2mg/ml colcemid (Demecolcine, Sigma–Aldrich, Milan, 
Italy) for 4 h. Cells were harvested by trypsinization, swollen in 75mM KCl at 37°C, fixed 
with 3:1 methanol/acetic acid (v/v), and dropped onto clean, ice-cold glass microscope 
slides. The slides were air dried and stained with 3% GIEMSA a in phosphate-buffered 
saline for 10 min. Chromosome numbers were evaluated by looking at least 50 metaphases 
for each sample using a Zeiss Axioskop microscope under a 63X objective. The 
experiment was repeated at least twice. The statistical analysis was done by using the 
Student’s t-test. 
5.8 Immunofluorescence microscopy 
To visualize b-tubulin cells were grown on rounded glass coverslips and then fixed 
with Ethanol/Acetic acid 95:5 for 10 min, permeabilized with 0.1% TritonX (Sigma-
Aldrich, Milan, Italy) in PBS for 15 min and blocked with 0.1% Bovine Serum Albumin 
(BSA) for 30 min, both at room temperature. Coverslips were incubated with a mouse 
monoclonal antibody against β-tubulin mouse (1:200, Sigma–Aldrich, Milan, Italy) over-
night at 4° C, followed by a goat anti-mouse IgG-FITC secondary antibody (Sigma–
Aldrich, Milan, Italy, diluted 1:100 in PBS) for 1 h at 37° C. Nuclei were visualized with 1 
mg/ml of 40,6-Diamidino-2-phenylindole (DAPI) and examined on a Zeiss Axioskop 
microscope equipped for fluorescence, images were captured with a CCD digital camera 
(AxioCam, Zeiss, Milan, Italy) and then transferred to Adobe PhotoShop for printing. We 
evaluated at least 100 mitoses for each sample. The experiment was repeated twice. 
 
5.9 Senescence-associated b-galactosidase activity assay 
Senescence-Associated βGalactosidase (SA-βGal) activity was measured 72 h after 
siMAD2 RNA transfection, cells were washed in PBS, fixed for 3min (room temperature) 
in 2% paraformaldehyde, washed, and incubated for 24 h at 37°C (no CO2) with fresh SA-
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βGal stain solution: 1 mg/ml 5-bromo-4-chloro-3-indyl-D-galactopylanoside (X-Gal, 
SIGMA),  5mmol/L potassium ferrocyanide, 5 mmol/L potassium ferricyanide,150 
mmol/L NaCl, 2 mmol/L MgCl2, 0.01% sodium deoxycholate, and 0.02% Nonidet-40 
(Lentini et al. 2012). Senescent cells were evaluated using a Zeiss Axioskop microscope 
under a 20X objective (100 cells/sample). The experiment was repeated twice. 
5.10 Acridine Orange/Ethidium Bromide Assay 
Acridine orange (AO) permeates all cells and makes the nuclei to appear green. 
Ethidium bromide (EB) is only taken up by cells when cytoplasmic membrane integrity is 
lost and stains the nucleus in red. Thus, live cells have a normal green nucleus, apoptotic 
cells have bright green nucleus with condensed or fragmented chromatin; cells died from 
direct necrosis have a structurally normal orange–red nucleus. Floating cells were collected 
in a 15ml tube, adherent cells were harvested by trypsinization and added to the same 15 
ml tube. Cells were centrifuged and resuspended in AO/ EB solution then dropped onto 
glass microscope slides. Apoptotic cells were evaluated by using a Zeiss Axioskop 
microscope with a 20X objective. At least 150 cells for each sample were scored and the 
experiment was repeated twice.  
5.11 Statistical analysis 
All experiments were repeated at least twice and statistically analyzed by the 
Student’s t-test. In the figures the symbol *** indicates a Pvalue<0.001, ** indicates a P 
value <0.01 and the symbol * indicates a P value <0.05. 
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